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The current public concern about methicillin 
resistant Staphylococcus aureus (MRSA) has yet to 
extend to antibiotic resistance in general and its 
relationship to our stewardship of anti-microbial use. 
Since the 1970s, there has been an increase in both 
the number of anti-microbial prescriptions and in 
the preference for broad-spectrum agents. In Ireland 
in primary care, we are better than some but are 
worse than other European countries. Irish defined 
daily doses of antibiotic are 20 per 1,000 inhabitants, 
compared with 15 per 1,000 in the UK, 10 per 1,000 
in the Netherlands and 2.2 per 1,000 in France.1  
Overall, anti-microbial resistance is lowest in the 
Nordic countries and Austria and highest in Portugal 
and Spain.
Whereas we all believe in the least toxic, least 
expensive agent with the narrowest spectrum 
of activity for the shortest possible time and in 
the avoidance of anti-microbial agents for viral 
infections, most of us break these principles 
repeatedly. Reasons may include pressure from 
patients to prescribe for all possible infections, 
marketing by pharmaceutical companies and a 
perceived need to cover all possibilities with empiric 
broad-spectrum therapy in all febrile patients in 
a litigious society. Provision of timely culture and 
sensitivity data should allow for better antibiotic 
stewardship. However, in hospital practice in some 
instances, it paradoxically can lead to broader 
spectrum therapy to cover all reported isolates, even 
when these culture results are of commensals or 
contaminants. We need greater wisdom and restraint 
in anti-microbial prescription or we will end up in a 
post-antibiotic age. For urinary tract infection (UTI), 
common errors include poor selection of agents, in 
appropriate therapy of asymptomatic bacteriuria in 
the elderly and in catheterised patients and failure to 
choose short course therapy for women with cystitis. 
Anti-microbial therapy for community-acquired 
UTI in most instances must be given empirically, 
so knowledge of local anti-microbial sensitivity 
patterns is essential for general practitioners. In 
this issue, Ni Chulain et al provide valuable data 
on in-vitro susceptibilities to anti-microbial agents 
for consecutive urinary isolates of Escherichia 
coli (almost 1,000), in the West of Ireland over a 
defined time period. The majority (77.1%) were from 
general practice. Mid-stream urine (MSU) from 
patients with repeated difficulties with UTI may 
have been preferentially submitted, leading to an 
overestimation of the true prevalence of resistance. 
Pyuria and clinical findings are not reported, so some 
contaminants may have been included, due to delay 
in transport and failure to refrigerate. Despite these 
caveats, the paper provides a valuable description 
of in vitro resistance that should influence anti-
microbial prescribing for UTI, in the context of a need 
to improve antibiotic stewardship.  
This paper reports that more than 50% of E. coli 
are resistant to ampicillin and amoxycillin, more 
than 40% are resistant to sulphonamides and 0% 
to trimethoprim and to tetracycline. Although 
therapy may still succeed for lower tract infection 
in some cases in the face of in-vitro resistance, due 
to high and prolonged urinary excretion (as much 
as 50% success in the case of trimethoprim),2  these 
agents can no longer be relied upon for UTI, in the 
absence of a definitive MSU report showing that the 
pathogen is susceptible.  
For co-amoxiclav, resistance rates varied from 
7.9% in the community to 12.5% in hospital, with 
approximately one in five of the total exhibiting 
intermediate susceptibility. Co-amoxiclav can still 
be relied upon in most instances, but it is likely that 
the prevalence of resistance will increase in the near 
future above a threshold of 20%, at which time it 
will also have to be abandoned for empiric use in 
UTI. As a beta-lactam, it has disadvantages that go 
beyond in-vitro susceptibility, in that clinical studies 
have shown that penicillins and cephalosporins have 
higher failure rates in comparison to non-cell wall 
active agents, even when the isolate is fully sensitive. 
The relationship between in-vitro susceptibility 
and clinical response in UTI is not straightforward. 
Randomised controlled comparisons of beta-
lactam agents to non-cell wall active agents have 
consistently shown the superiority of the latter for 
UTI, and in vitro susceptibilities do not explain the 
variation. This comparison holds up when nalidixic 
acid is compared to cephalexin, when amoxycillin is 
compared to co-trimoxazole,4 and when ciprofloxacin 
is compared to co-amoxiclav.5  This concept derived 
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from randomised controlled trials does not influence 
anti-microbial choice for UTI in Ireland at present. 
The ciprofloxacin resistance rate of 6% in hospital 
isolates and 2.5% in the community also indicates that 
fluoroquinolones can be relied upon empirically in 
most instances. However we are concerned that the 
effectiveness of this valuable class of anti-microbial 
agents will also be lost. In the USA, ciprofloxacin 
was the only agent that demonstrated a consistent 
stepwise increase in resistance in urinary isolates 
from 1995 (0.7%) to 2001 (2.5%).6  Similarly in the 
Netherlands, resistance to norfloxacin increased from 
1.% in 1989 to 5.8% in 1998.7 Rates of resistance to 
community UTI isolates have reached 17% in Italy,8 
25% in Turkey9 and 2% in Spain.10 
This increasing resistance to fluoroquinolones may 
result in the loss of a very valuable anti-microbial 
agent, especially for patients with life-threatening 
infections. Efforts should therefore be made to 
curtail fluoroquinolone use. More widespread use 
of fluoroquinolones for UTI may add to pressures 
resulting from their increasing use for respiratory 
tract infection. Used either alone or with penicillin, 
fluoroquinolones are justified for community-
acquired pneumonia (CAP) of moderate or greater 
severity, but not for mild pneumonia, bronchitis, 
exacerbation of chronic obstructive pulmonary 
disease (COPD) and sinusitis. In UTI, their use should 
be limited to septic patients with moderate to 
severe pyelonephritis. For these patients admission 
to hospital and an additional agent such as an 
aminoglycoside is also justified, while awaiting the 
results of blood and urine cultures in the emergency 
room. For others with cystitis or mild or silent upper 
tract infection without sepsis, alternatives are 
strongly encouraged, of which older, less expensive 
urinary antiseptics should take precedence. It is 
not generally appreciated that nalidixic acid is a 
quinolone.11  If resistance is selected for it, then 
in some but not all cases, this will spill over to 
ciprofloxacin, ofloxacin and moxifloxacin. 
In contrast, nitrofurantoin does not share cross-
resistance with more commonly prescribed anti-
microbial agents. The consistent susceptibility 
of E. coli to nitrofurantoin may be due to 
nitrofurantoin’s narrow spectrum of activity, 
limited indication (treatment of acute cystitis), 
narrow tissue distribution (low or undetectable 
serum concentrations), and limited contact with 
bacteria outside the urinary tract. It has the 
advantage of low cost, good tolerability, and safety 
in pregnancy. Efficacy has been well demonstrated 
for nitrofurantoin in clinical studies. Disadvantages 
include its four times per day administration 
and that it is not effective for the patient with 
bacteraemia.
 
Fosfomycin also had good clinical trials to validate its 
use, with very good response rates and consistently 
very low in-vitro resistance rates internationally, but 
was discontinued some time ago in Ireland.12, 1
In women with lower tract symptoms, who are 
without fever or renal tenderness, short course 
therapy of three days duration or even single dose 
therapy will suffice. Women with bladder symptoms 
of greater than seven days duration or who have had 
a recent failure of therapy for UTI are at risk of silent 
upper tract infection and, like men, should be treated 
for seven to 10 days.14 
Symptomatic lower urinary tract infection (cystitis) 
will occur at least once in about one third of all adult 
women.  A rare minority will have such frequent 
relapses that continuous prophylaxis is justified. In 
contrast to adult males and children, the proportion 
with underlying structural disorders of the renal 
tract is so low that referral for urological evaluation 
and imaging of the upper tract should be limited 
only to those women who have had a relapse of 
pyelonephritis.
 
In elderly patients of both sexes, asymptomatic 
bacteriuria is much more frequent than 
symptomatic UTI and should not be treated. There 
is a high frequency of spontaneous cure and re-
infection. Anti-microbial therapy will not alter 
this and is only recommended if the patient has 
symptoms. In contrast asymptomatic bacteriuria in 
children or in pregnant women should be treated, if 
confirmed on a repeat MSU. Asymptomatic catheter-
acquired UTI should not be treated as this will lead 
to emergence of more resistant organisms. 
REFERENCES
1. Goossens H, Ferech M, Vander Stichele R et al. 
Outpatient antibiotic use in Europe and association 
with resistance: a cross-national database study. Lancet. 
2005 Feb 12-18; 65(9459): 548-9.
2. Johnson JR. Fluoroquinolones in urinary tract infection. 
Milestones in drug therapy: Fluoroquinolone antibiotics 
200 Birkhauser: 107-19.
. Preiksaitis JK, Thompson L, Harding GK et al. A 
comparison of the efficacy of nalidixic acid and 
cephalexin in bacteriuric women and the effect on fecal 
and periurethral carriage of enterobacteriaceae. J Infect 
Dis 1981; 14 (4): 60-8.
4. Stamm WE, McKevitt M, Counts GW. Acute renal 
infection in women: treatment with trimethoprim-
sulfamethoxazole or ampicillin for two or six weeks. A 
randomized trial. Ann Intern Med. 1987 Mar;106():41-5. 
5. Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-
clavulanate vs ciprofloxacin for the treatment of 
uncomplicated cystitis in women: a randomized trial. 
JAMA 2005; 29: 949-55.
6. Karlowsky JA, Kelly LJ, Thornsberry C et al. Trends in 
antimicrobial resistance among urinary tract infection 
isolates of Escherichia coli from female outpatients in 
the United States. Antimicrob Agents Chemother. 2002 
Aug; 46(8): 2540-5.
7. Goettscha W, van Pelta W, Nagelkerkea N et al. 
Increasing resistance to fluoroquinolones in Escherichia 
coli from urinary tract infections in The Netherlands J 
Antimicrob Chemother. 2000 Aug; 46(2): 22-8.
8. Fadda G, Nicoletti G, Schito GC et al. Antimicrobial 
susceptibility patterns of contemporary pathogens 
from uncomplicated urinary tract infections isolated 
in a multicenter Italian survey: possible impact on 
guidelines. J Chemother. 2005 Jun; 17(): 251-7.
9. Karaca Y, Coplu N, Gozalan A et al. Co-trimoxazole and 
quinolone resistance in Escherichia coli isolated from 
urinary tract infections over the last 10 years. Int J 
Antimicrob Agents 2005 Jul; 26(1): 75-7.
10. Andreu A, Alos JI, Gobernado M et al. Aetiology and 
antimicrobial susceptibility among uropathogens 
causing community-acquired lower urinary tract 
infections: a nationwide surveillance study. Enferm 
Infect Microbiol Clin. 2005 Jan; 2(1): 4-9.
11.  Sheehan G, Chew N. The history of quinolones. 
Milestones in drug therapy: Fluoroquinolone 
antibiotics.200 Birkhauser: 1-10.
12. Kahlmeter G. An international survey of the 
antimicrobial susceptibility of pathogens from 
uncomplicated urinary tract infections: the ECOSENS 
Project. J Antimicrob Chemother. 200 Jan; 51(1): 69-76.
1. Alos JI, Serrano MG, Gomez-Garces JL, Perianes 
J. Antibiotic resistance of Escherichia coli from 
community-acquired urinary tract infections in relation 
to demographic and clinical data. Clin Microbiol Infect. 
2005 Mar; 11(): 199-20.
14. Sobel J, Kaye D. Urinary tract infections. Mandell, Douglas 
and Bennett’s Principles and practice of infectious 
diseases. 2005, 6th Edition; Chapter 66: 875-905.
Correspondence to : Dr. G Sheehan, 
E-mail:gsheehan@iol.ie
G Sheehan, n Chew ANTI-MICROBIAL STEwARDSHIP FOR URINARY TRACT INFECTION
8 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4
O
R
IG
IN
A
L 
PA
P
E
R
O
R
IG
IN
A
L 
PA
P
E
R
IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4  9
InTRODUCTIOn
Urinary tract infection (UTI) is one of the more 
common infectious diseases presenting in both the 
community and hospital. E. coli is the most common 
organism associated with urinary tract infection 
accounting for more than 70% of UTIs in many 
series.1,2 Uncomplicated UTI is frequently managed 
empirically without laboratory investigation. Agents 
commonly used for treatment of UTI include beta-
lactam antimicrobial agents such as amoxicillin and 
co-amoxiclav, and agents such as nitrofurantoin and 
nalidixic acid that are used exclusively for treatment 
of UTI. Guidelines from the Infectious Disease 
Society of America recommend co-trimoxazole 
(trimethoprim-sulphamethoxazole) for three days, as 
the current standard of therapy for uncomplicated 
cystitis while acknowledging that trimethoprim 
alone is equivalent.4 Ofloxacin and probably 
other fluoroquinolones such as ciprofloxacin are 
considered equivalent to co-trimoxazole but for 
therapy of uncomplicated cystitis these agents 
are considered unnecessary for routine empirical 
therapy unless rates of resistance to co-trimoxazole/
trimethoprim exceed 10 to 20% among bacteria 
associated with urinary tract infection.4 
A previous publication examining 171 uropathogenic 
E. coli from this region in 1997 documented 
high levels of resistance to ampicillin (54%) and 
trimethoprim (29%). There are few recent data 
in the peer-reviewed literature on susceptibility 
patterns among uropathogenic E. coli isolates in 
Ireland. We have studied 94 consecutive, non-
duplicate E. coli isolates associated with urinary 
tract infection in the period September 2002 to 
January 200 to determine rates of antimicrobial 
resistance in this region. Susceptibility testing 
included antimicrobial agents commonly used for 
treatment of UTI in Ireland. Cefpodoxime is not 
generally used in Ireland but was chosen to represent 
extended spectrum cephalosporins because it is 
particularly useful in screening for the antimicrobial 
resistance phenomenon know as extended-spectrum 
Antimicrobial resistance in E. Coli 
associated with urinary tract infection in the 
West of Ireland
ABsTRACT
Background  Knowledge of antimicrobial resistance patterns in E. coli, the predominant 
pathogen associated with urinary tract infection (UTI) is important as a guide in 
selecting empirical antimicrobial therapy.
Aims To describe the antimicrobial susceptibility of E. coli associated with UTI in a region 
in the West of Ireland. 
Methods  A collection of 94 E. coli isolates associated with UTI were tested for 
susceptibility to a panel of antimicrobial agents by the disc diffusion method of the 
National Committee for Clinical Laboratory Standards. 
Results  More than 50% of E. coli were resistant to ampicillin, more than 40% resistant 
to sulphonamide and more than 0% resistant to trimethoprim. From 7.9% 
(community) to 12.5% (hospital) are resistant to co-amoxiclav with approximately 
20% of isolates of intermediate susceptibility. In general practice most E. coli remain 
susceptible to nitrofurantoin (96.7%), nalidixic acid (9.9%) and ciprofloxacin 
(94.7%). For all agents rates of resistance were higher in hospital as compared with 
general practice isolates. Three isolates with the phenotype of Extended Spectrum 
Beta-lactamase (ESBL) resistance were detected.
Conclusions  Ampicillin/amoxicillin are not suitable for empiric therapy of UTI in 
general practice or hospital patients in this region. There is doubt as to the role of 
trimethorpim or co-trimoxazole for empiric therapy of UTI. Nitrofurantoin, nalidixic 
acid and ciprofloxacin are active against the great majority of UTI associated E. coli.
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beta-lactamase production.5 A number of other 
antimicrobial agents (such as chloramphenicol, 
cefoxitin, kanamycin and streptomycin) were 
included because they are of interest as markers 
for the extent of dissemination of antimicrobial 
resistance determinants.
MATERIALs AnD METHODs
Specimens were submitted from hospital 
inpatients and from general practitioners. E. coli 
were considered clinically significant if present at 
a count of greater than 100,000/ml and in pure 
culture. Consecutive isolates were collected from 
September 2002 to January 200. Identification 
as E. coli was based on characteristic pink colony 
colour on Oxoid chromogenic urinary tract infection 
(UTI) medium. Antimicrobial susceptibility testing 
was performed by the disc diffusion method of 
the National Committee for Clinical Laboratory 
Standards (NCCLS, now know as the Clinical 
Laboratory Standards Institute).6 The following 
antimicrobial agents were tested ampicillin (10µg), 
co-amoxiclav (20/10µg), nalidixic acid (0µg), 
nitrofurantoin (00µg), sulphonamide (00µg), 
trimethoprim (5µg), gentamicin (10µg), cefoxitin 
(0µg), cefpodoxime (10µg), cefpodoxime/clavulanic 
acid (10/1µg), kanamycin (10µg), streptomycin (10µg), 
tetracycline (0µg), chloramphenicol (0µg) and 
ciprofloxacin (5µg). Escherichia coli ATCC® 25922 and 
ATCC® 5218 were used as controls. Isolates resistant 
to cefpodoxime were tested for production of ESBL’s 
by the NCCLS ESBL disc method with cefpodoxime 
and cefpodoxime/clavulanate. Isolates positive on 
this disc test were confirmed by ESBL Etest strips 
with cefotaxime, ceftazidime and cefpirome with 
and without clavulanic acid.5 
REsULTs
Nine hundred and thirty-four consecutive isolates 
(94) were collected. The majority of isolates (77.1%, 
72 isolates) originated from general practice. The 
remaining 22.9% of isolates were from hospital 
inpatients. The results are summarised in Table 1. 
Key observations include high rates of resistance to 
ampicillin (in excess of 50%) in both hospital and 
community E. coli isolates. The rates of resistance 
to trimethoprim and sulphonamide at greater than 
0% and greater than 40% respectively are also 
very high. For co-amoxiclav, although only 7.9% 
(GP) to 12.5% (hospital) of isolates are resistant 
approximately 1 in 5 isolates (16.9% of GP and 24% of 
hospital isolates) exhibit intermediate susceptibility. 
Of agents commonly used to treat UTI and included 
in this study, only nitrofurantoin and ciprofloxacin 
are active against more than 90% of hospital and 
general practice isolates but nalidixic acid retains 
Table 1
ANTIMICROBIAL SUSCEPTIBILITY OF E.COLI ISOLATES ASSOCIATED wITH URINARY TRACT INFECTION
ANTIMICROBIAL AGENT
HOSPITAL ISOLATES COMMUNITY ISOLATES
% RESISTANT % SUSCEPTIBLE % RESISTANT % SUSCEPTIBLE
Ampicillin 52.1 4.1 52.1 45.6
Amoxicillin/Clavulanic Acid 12. 6.5 7.9 74.
Nalidixic Acid 12. 86.7 5.9 9.
Ciprofloxacin 4. 92.9 2.5 95.
Nitrofurantoin 5.2 9.4 .2 96.5
Trimethoprim 5.5 6.0 0.5 69.1
Sulphonamides 44.1 55.5 42. 57.7
Cefpodoxime 4.7 9.8 2.1 95.8
Cefoxitin 1.9 96.2 1.4 97.6 
Gentamicin 2.4 97.6 1.4 98.5
Kanamycin 8.1 88.6 6.5 92.6
Streptomycin 6.0 57.8 2.6 62.7
Tetracycline 0.8 69.2 0.9 68.6
Chloramphenicol 10.4 89.6 7.2 92.7
Where % susceptible and % resistant do not equal 100% the remaining isolates were categorised as intermediate.
ANTIMICROBIAL RESISTANCE IN E. COLI ASSOCIATED wITH URINARY TRACT INFECTION IN THE wEST OF IRELAND M ni Chulain et al
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activity against more than 90% of isolates of E. coli 
from general practice. Three isolates were confirmed 
as producing extended spectrum β-lactamase like 
enzymes. Two of these isolates are from patients 
in the community and one is from a hospitalised 
patient. Further characterisation of the enzymes 
present in these strains is in progress. 
In total, 27% of isolates obtained from hospital 
inpatients and 1% of isolates obtained from 
patients in the community were susceptible to all 
antimicrobial agents tested. Multi-drug resistance 
is common with resistance to between 5 and 10 
antimicrobial agents tested observed in 26.5% 
of isolates from hospital patients and 20.9% of 
isolates obtained from General Practice. A small 
number of isolates (2.8% of isolates from hospital 
and 1.1% of isolates from General Practice) were 
resistant to more than 10 antimicrobial agents. At 
least one of the panel of oral antimicrobial agents 
commonly used for treatment of UTI and included 
in this study (ampicillin, co-amoxiclav, trimethoprim, 
nitrofurantoin, nalidixic acid and ciprofloxacin) 
were active against all but two of the isolates. Both 
of these isolates were isolated from specimens 
submitted from General Practice and were resistant 
to 12 or more antimicrobial agents.  
DIsCUssIOn
Urinary tract infection, particularly cystitis is a very 
common condition that most doctors are called upon 
to treat from time to time. Approximately one in three 
women will have at least one UTI before the age of 
24 years.7 Empirical antimicrobial therapy is a widely 
accepted approach to management of UTI. Data on 
which to base a rational decision regarding choice 
of antimicrobial agent are required. Some caution 
is required in interpretation of our data however as 
it is possible, particularly in relation to specimens 
from general practice, that the specimens submitted 
may represent a subset of patients with complicated 
infection or infection that has failed to respond to 
initial empiric therapy. Furthermore this study did 
not include uropathogens other than E. coli. Such 
factors could lead to overestimation of the prevailing 
level of antimicrobial resistance in patients with 
UTI. It is interesting to note that overall the findings 
are very similar to a recent multi-centre UK study.1  
Rates of resistance to streptomycin, kanamycin, 
chloramphenicol and tetracycline are of limited 
therapeutic interest as these agents are not routinely 
used for treatment of urinary tract infection and 
with the exception of tetracycline are rarely used 
now in human health care. The rates of resistance 
to these agents are of interest primarily as a marker 
of the extent to which antimicrobial resistance 
determinants have disseminated in bacterial 
populations and the extent to which the may persist 
even when the agents have been all but eliminated 
from use in human health care.
Although recognising the limitations and possible 
bias of this study it is important to attempt some 
practical recommendations for empiric therapy. 
We consider that ampicillin and the related agent 
amoxicillin cannot be considered as suitable agents 
for empiric therapy of UTI. The status of co-amoxiclav 
as an empiric choice is less clear-cut as the great 
majority of non-susceptible isolates are intermediate 
rather than frankly resistant. Similar rates of 
resistance to aminopenicillins and to co-amoxiclav 
were recently reported from UTI associated E. coli 
in the UK.1 On balance we would caution against 
general use of co-amoxiclav for empiric therapy of 
UTI given the high rate of intermediate susceptibility 
and recent evidence that, even in the context of full 
susceptibility, co-amoxiclav is inferior to ciprofloxacin 
for short course (that is three days) therapy of 
uncomplicated cystitis.8
More than 90% of isolates are also susceptible 
to the beta-lactam cefpodoxime. Susceptibility 
to cefpodoxime can be taken as confirming 
susceptibility to parenteral cephalosporins such 
as cefotaxime or ceftriaxone. Cefpodoxime 
susceptibility does not confirm susceptibility to oral 
cefuroxime. A recent UK study suggests that less 
than 70% of uropathogenic E. coli are susceptible 
to oral cefuroxime.1 There is some concern that the 
relatively low microbiological cure rate observed 
with co-amoxiclav for short course therapy of 
uncomplicated cystitis may be a general property of 
penicillins and cephalosporins. It is also important 
to note that a small number of isolates resistant 
to broad-spectrum cephalosporins and with a 
resistance phenotype consistent with Extended 
Spectrum Beta-lactamase (ESBL) production 
were detected in this study. Studies to define the 
molecular mechanisms of resistance in these isolates 
are ongoing. As with amoxicillin and co-amoxiclav, 
the routine use of cephalosporins for short course 
therapy of UTI may be best avoided. The penicillins 
and cephalosporins may be useful when there are 
relative or absolute contraindications to other agents.
High levels of resistance to trimethoprim and 
sulphonamide cast doubt on the suitability 
of trimethoprim alone, or the combination of 
trimethoprim-sulphamethoxazole (co-trimoxazole) 
for empiric therapy. These findings are also similar to 
recent UK data showing that only 7.% of E. coli 
are susceptible to trimethoprim and only 62.% 
are susceptible to suphamethoxazole.1 In this 
context trimethoprim and co-trimoxazole can 
not be regarded as reliable agents for empirical 
therapy of UTI. These agents remain valuable when 
susceptibility is confirmed by laboratory testing.
Gentamicin remains active against most community 
and hospital uropathogenic E. coli isolates but its 
clinical use is limited by toxicity and the requirement 
for parenteral administration.
The susceptibility of over 90% of E. coli isolates to 
nitrofurantoin is also consistent with the recent UK 
data. Nitrofurantoin therefore has retained its role in 
treatment of uncomplicated cystitis in patients who 
can adhere to the four times per day dosing regimen. 
The IDSA guidelines suggest that in circumstances 
where trimethoprim resistance is very common 
fluoroquinolone antimicrobial agents are the 
drugs of choice for empiric treatment of UTI. In 
keeping with recent UK data, our data confirm that 
resistance to fluoroquinolone agents is uncommon. 
Resistance to the closely related but less potent 
compound nalidixic acid (a quinolone) is also 
uncommon in isolates from the community but 
rather more common in hospital isolates. Therefore 
nalidixic acid and fluoroquinolones can be expected 
to be effective for empiric treatment of UTI in the 
majority of cases. In the context of our data the 
more general use of fluoroquinolones such as 
ciprofloxacin or ofloxacin for empiric therapy of 
UTI would be consistent with IDSA guidelines and 
with clinical trial data on efficacy.4,8 This approach 
will ensure effective first line empiric therapy of 
UTI in the vast majority of cases. However this 
must be balanced against the obligation of the 
profession to prescribe antimicrobial agents in ways 
that minimise emergence of resistance. There are 
well-founded concerns that more extensive use of 
fluoroquinolones will result in increasing resistance 
to these agents.2 Use of the older quinolone agent, 
nalidixic acid may drive emergence of resistance to 
fluoroquinolones even more quickly than use of the 
fluoroquinolones themselves. This is because acquired 
resistance to quinolones/fluoroquinolones typically 
occurs in a step wise manner with only one mutation 
step required for emergence of resistance to nalidixic 
acid but with two mutation steps required for 
emergence of resistance to fluoroquinolones.9
Given the serious implications in terms of potential 
for emergence of resistance and the costs of a policy 
of more general use of fluoroquinolone agents we 
are cautious in making such a recommendation. Well 
structured multi-centre surveillance based on sentinel 
practices such as that described by Hummers-Pradier 
et al. is desirable to provide a more authoritative basis 
for recommendations regarding empiric therapy 
of UTI.10 At present it may be appropriate to use 
nitrofurantoin where it is practical to do so, to seek 
initial laboratory confirmation where the delay in 
initiation of therapy is acceptable and to limit empiric 
fluoroquinolone use to patients with more severe 
symptoms, those at high risk of complications and 
those who have failed to respond to or are unlikely to 
adhere to therapy with nitrofurantoin. It is important 
also to bear in mind that fluoroquinolones are not 
recommended for use in children or during pregnancy.
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InTRODUCTIOn
Ireland has the fourth and ninth highest number 
of colorectal cancer (CRC) cases for men and 
women in the European Union, making up 8.9% of 
all cancers diagnosed.1 CRC has now become the 
leading non-cutaneous cause of cancer in Ireland, 
with an age adjusted rate of 49.8 per 100,000.2 By 
contrast, the age adjusted rates per 100,000 for 
European and United States populations are 44 and 
46. respectively.2 In addition, 12.6% of all cancer 
deaths were attributable to CRC in 1999, making 
it the second most common cause of death from 
cancer. Up to 20% of Irish patients still present with 
metastatic disease4, emphasising the need for better 
prevention and early detection of tumours through 
strategic measures such as screening.
The implementation of endoscopic based screening 
programmes has gained widespread acceptance in 
many countries with numerous trials showing both 
a decrease in incidence and mortality from colorectal 
carcinoma.5-8 Thus, American Cancer Society 
recommendations for screening include one of the 
following, beginning at age 50; a faecal occult blood 
test (FOBT) and flexible sigmoidoscopy (repeated 
every five years with FOBT annually if normal), or 
colonoscopy (repeated every 10 years if normal), or 
double-contrast barium enema (repeated every five 
to 10 years if normal). A digital rectal examination 
should be done at the same time as sigmoidoscopy, 
colonoscopy, or double-contrast barium enema.9
The publication of colorectal cancer management 
guidelines by the Royal College of Surgeons in Ireland 
has provided clinicians in Ireland with a benchmark 
of clinical care and emphasises the importance of 
a multidisciplinary approach to ensure acceptable 
rates of anastomotic leak, operative mortality, 
recurrence, and survival. However, the overall five-
year survival for CRC is approximately 6.5% and 
the long-term outcome for CRC patients has not 
significantly changed over the past two decades 
despite apparent improvements in diagnosis, 
surgical options, and adjuvant therapy.10 The total 
survival rate from cancer registries includes patients 
presenting with advanced disease many of whom are 
treated non-operatively.2, However, in patients who 
undergo surgery for colorectal cancer, a significant 
survival advantage is seen. Patients who have surgery 
have a five-year survival of 5.4% compared to 14.1% 
in patients who do not.4 Although previous Irish 
surgical data have been published from individual 
units,11,12 no previous large series (from a single 
surgeon’s perspective) of Irish patients examining 
changes in outcome over time has been published. 
The purpose of this study therefore, was to evaluate 
Changes in outcome following surgery for 
colorectal cancer: one surgeon’s experience
ABsTRACT
Background  Colorectal cancer (CRC) has the second highest mortality rate of all cancers 
in Ireland. Developments in imaging, surgical technique, and perioperative care in 
the last two decades have altered management.
Aims To determine whether outcome following surgery for CRC in the mid-west has 
changed over a 22-year period.
Methods  Four hundred and twenty-two patients were divided into two time periods: 
Group A (1980-1991, n=20) and Group B (1992-2002, n=219) and demographic, 
inpatient, and survival data were reviewed. 
Results  The mean age was 67 years, 59% were male. Group B patients had less advanced 
disease at presentation (Dukes’ stage D 14% vs 22%, p<0.05), fewer perioperative 
complications (1% vs 2%, p<0.05), and fewer local recurrences (6.8% vs 11.8%, p<0.05) 
than Group A. No difference in 0-day mortality rate or survival was detected.
Conclusions  Although perioperative CRC management has improved, methods of earlier 
diagnosis and improvements in adjuvant therapy should be explored to 
improve survival.
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clinical and pathological factors in patients treated 
by a single colorectal surgeon over a period of 
22 years and identify any trends and changes in 
outcomes over this time period. 
MATERIALs AnD METHODs
Patient population
A retrospective analysis of patients undergoing 
treatment for primary colorectal carcinoma at the 
Midwestern Regional Hospital, Limerick over a 22-
year period from 1980 to 2002 was performed. Eight 
hundred and twenty-six patients who underwent 
a major abdominal procedure under the care of a 
single surgeon (PVD) were initially identified from 
operating-theatre records and their medical records 
(or microfilmed charts) were retrieved. Seventy-
seven patient records were unavailable for analysis 
due to lost or destroyed records or poor quality of 
microfiche data.
Records were then examined to ensure accurate and 
complete demographic and operative details and to 
exclude non-colorectal cancer cases. A total of 422 
patients with adequate records were identified. The 
demographic, clinical, pathologic, and follow-up data 
were then collected and entered into a database. 
In order to identify any trends over the 22 years, 
the group of 422 patients was then divided into 
two time periods; 1980 – 1991 (Group A) and 1992 
– 2002 (Group B). Approval to conduct the study was 
obtained from the internal ethical review committee. 
Demographic and clinicopathological characteristics
Group A comprised 20 patients and Group B 219 
patients. The male to female ratio was 1.5:1. The mean 
age of patients was 66.8 years and the median age 
was 68 years, with an age range of 1 to 99 years 
(Table 1). One-third of patients were over 75 years of 
age at presentation and 16% were less than 55 years at 
presentation. The two groups did not differ significantly 
with respect to age or gender. Elective or emergency 
surgery (defined as the presence of obstruction or 
perforation at presentation) and type of operation 
were recorded. Operations were sub-categorised 
according to the region of the colon or rectum (Table 
2). All rectal tumours were histologically proven 
adenocarcinomas and located 12 cm proximal to the 
anal verge as shown by rigid rectosigmoidoscopy. 
Tumours requiring low-anterior resection were 
approximated to 5cm from the dentate line. Dukes’ 
stage, presence of metastases and subsequent liver 
resection, and pre- or post-operative chemoradiation 
or hepatic artery infusion were also recorded. 
Table 1
PATIENT DEMOGRAPHICS
GROUP A GROUP B
Number 20 (48%) 219 (52%)
Male Gender 58% 61% 
Mean Age, years 65.4 68.1
Median Age, years 66 68
Age Range, years 1-90 1-99
Table 2
OPERATION TYPE BY GROUP
GROUP A 
N (%)
GROUP B 
N (%)
Right Hemicolectomy 8 (18.7) 44 (20.1)
Transverse Colectomy 4 (2.0) 5 (2.)
Subtotal Colectomy  (1.5) 11 (5.0)
Total Colectomy 4 (2.0) 4 (1.8)
Left Hemicolectomy 1 (6.4) 8 (.7)
Sigmoid Colectomy  (1.5) 6 (2.7)
Anterior Resection (AR) 67 (.0) 61 (27.9)
Low Anterior Resection (LAR) 20 (9.9) 0 (1.7)
Abdominoperineal 
Resection (APR)
20 (9.9) 20 (9.1)
Hartmann’s Procedure 14 (6.9) 16 (7.)
Exploratory Laparotomy 2 (1.0) 1 (0.5)
Bypass 1 (6.4) 1 (5.9)
Transanal Resection 2 (1.0) 0
Table 3
MORBIDITY & MORTALITY
GROUP 
A
GROUP 
B
OVERALL
Complications, % 2.2 1.2* 18.0
30-Day Mortality, % 6.4 7.8 7.1
Complication Type, %
Symptomatic 
Anastomotic Leak
2.5 .2 2.8
Wound infection 5.4 1.0* 2.8
Cardio-pulmonary 6.9 1.4* 4.0
Sepsis 1.0 1.4 1.2
Other 4.9 2. .
*p<0.05 vs Group A
JM Kiely et alCHANGES IN OUTCOME FOLLOwING SURGERY FOR COLORECTAL CANCER: ONE SURGEON’S EXPERIENCE
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Morbidity and mortality
Morbidity was defined as any major complication 
that developed after surgery prolonging 
hospitalisation or requiring additional intervention. 
Complications included symptomatic anastomotic 
leak, wound infection, cardiopulmonary, 
thromboembolic, renal complications, and sepsis 
or any other major complication such as intestinal 
obstruction or rectovaginal fistula formation. The 
use of post-operative contrast enemas was not 
routinely employed to identify clinically unsuspected 
leaks. Operative mortality was defined as in-hospital 
death or death within 0 days of the procedure. 
Subsequent local or distant recurrence and time to 
recurrence also was examined. Local recurrence (LR) 
was defined as recurrence within the pelvis, with or 
without distant recurrence.
Follow-up and statistics
Follow-up and survival information was obtained 
from clinic notes, hospital records, patients’ 
general practitioners, or infrequently from patients 
or surviving relatives. Statistical analyses were 
performed using Student’s t test, or Chi-squared 
analysis where appropriate with statistical 
significance defined as p<0.05. Survival rates were 
analysed by the Kaplan-Meier actuarial method, with 
statistical significance determined by the log-rank 
statistic using SPSS statistical software (SPSS Inc., 
Chicago, Illinois).
REsULTs
Presentation and operation type
Fifty-five patients (1%) presented as emergencies 
with either intestinal obstruction or perforation. 
Of these patients 45.4% were over 75 years of age. 
Rates of emergency presentation did not differ 
between the two time periods (12.% vs 1.6%, p=ns). 
All procedures were categorised into 1 different 
types and are outlined in Table 2. Left-sided lesions 
were treated with 21 left hemicolectomies (5.0%), 
nine sigmoid colectomies (2.1%), 0 Hartmann’s 
procedures (7.1%) and 22 total/subtotal colectomies 
(5.2%). Eighty-two right hemicolectomies (19.4%) and 
nine transverse colectomies (2.1%) were performed 
for right-sided lesions. Of the 220 rectal lesions, 
anterior (n=128) or low anterior resections (n=50) 
were performed in 81% (n=178). Eighteen per cent of 
rectal cancers were treated with abdominoperineal 
resections and two transanal excisions were also 
performed. There were a total of 29 other procedures 
comprising 26 palliative bypass procedures and three 
exploratory laparotomies. Although some trends 
existed in the number of low anterior resections 
and subtotal colectomies performed, no significant 
differences in any operation type between the 
two groups were observed. There was no clear-cut 
policy on the use of a protective stoma for rectal 
surgery and no differences were seen between the 
two groups. Thirteen patients who developed liver 
metastases underwent liver resection. Two patients 
had an extended right lobectomy, three had right 
and left lobectomies each, and there were three 
segmental and two wedge resections performed.
Dukes’ Stage and Chemotherapy/Radiotherapy
Figure 1 illustrates the two groups according to 
Dukes’ Stage. Of tumours, 6.7% were Dukes’ Stage A, 
50.4% were Stage A, 25.2% were Stage C, and 17.7% 
were Stage D. Patients from the earlier time period 
(Group A) had a greater proportion of lesions that 
were Dukes’ Stage D compared to Group B (22.2% 
vs 1.6%, p<0.02), demonstrating that patients in 
the later time period had their disease identified 
at an earlier stage in its progression. Overall, % 
of patients underwent chemotherapy during the 
study period, but a significantly greater proportion 
of patients in Group B received chemotherapy 
compared to Group A (47.8% vs 14.8%, p<0.05). A total 
of 26 patients received post-operative hepatic artery 
infusion. Of these patients, 8.2% received radiotherapy, 
and the groups did not differ when radiotherapy 
rates were compared. There were insufficient data 
available to further define which patients received 
neo-adjuvant versus adjuvant radiotherapy.
Morbidity and mortality
Table  demonstrates complications in both groups. 
A total of 76 patients (18%) developed complications. 
Patients in Group A developed a significantly 
greater proportion of complications compared to 
Group B (2.2% vs 1.2%, p<0.02), demonstrating a 
downward trend in the incidence of complications 
for patients in the later time period. Twelve patients 
developed symptomatic anastomotic leaks for an 
overall leak rate of 2.8% and leaks were relatively 
evenly distributed between group A and B (2.5% vs 
.2%). Of patients in Group A, 5.4% had documented 
wound infections compared to 1.0% in Group B 
(p<0.002). Cardiopulmonary events were seen 
with greater frequency in the earlier time period 
(6.9 % vs 1.4%, p<0.05), and septic complications 
were similar between the groups. The proportion 
of other complications which included longer term 
occurrence of intestinal obstruction or rectovaginal 
fistula formation was similar between the groups.
Thirty patients in the series died within 0 days of 
their procedure for an overall 0-day mortality rate 
of 7.1% (Table ). The 0-day mortality rate between 
groups A and Group B did not differ significantly 
(6.4 vs 7.8%, p=ns). Twelve out of 55 patients who 
underwent emergency surgery died for an emergency 
operative mortality rate of 21.8%. Eighteen patients 
undergoing elective surgery died for an elective 
operative mortality rate of 4.9%. No difference in 
either elective or emergency operative mortality rate 
was observed between the two time periods.
Recurrence
The local recurrence rate was 9.2 % and a further 
10.7% developed distant recurrences. Interestingly, 
Group A patients had a local recurrence rate of 11.8% 
and distant recurrence rate of 6.8%, whereas Group 
B had a local recurrence rate of 6.8% and a distant 
recurrence rate of 1.7% and these differences were 
statistically significant (p<0.05) (Figure 2a). The local 
recurrence rate for rectal lesions in the series as a 
whole was 10.5%. The recurrence rate after anterior 
resection (AR) in Group A was significantly greater 
compared to Group B (18% vs .%, p<0.05) 
(Figure 2b). Recurrences after abdominoperineal 
resections (APR) and low-anterior resections (LAR) did 
not differ significantly between groups A and B. The 
mean and median time to overall local recurrence 
was 24. and 12 months.
Follow-up and survival
At the time of data analysis, 44.5% of patients were 
alive. The overall mean and median cumulative 
survival was 116 months and 84 months respectively 
(Figure a). One- and three-year survival was 78 and 
66% respectively. No difference in survival between 
the two groups was found (Figure b). Figure 4 
demonstrates overall survival according to Dukes’ 
Stage, with five-year survival rates of 8% for Dukes’ 
A, 74% for Dukes’ B, 48% for Dukes’ C, and 1% for 
Dukes’ D.
DIsCUssIOn
According to the most recent figures from the 
National Cancer Registry in Ireland2, colorectal 
carcinoma has a considerable and measurable 
impact on healthcare costs ranging from increased 
hospital activity to number of years of life lost due 
to premature death. CRC accounted for an average 
of 12 years of life lost or 11% overall, making it second 
only to lung cancer. In terms of hospital activity, the 
longest average length of stay was for CRC-related 
admissions at 16-17 days compared to, for example, 
Figure 2 —
EFFECT OF TIME 
PERIOD ON 
RECURRENCE RATES
Group A had a 
significantly greater 
proportion of patients 
with local recurrence 
compared with Group B. 
Group B had higher rates 
of distant recurrence 
compared to Group 
A (Figure 2a). Local 
recurrence rate after 
anterior resection (AR) 
was significantly higher 
in Group A compared to 
Group B but unchanged 
for abdominoperineal 
resection (APR) and low 
anterior resection (LAR) 
(Figure 2b).
Figure 1 —
EFFECT OF TIME 
PERIOD ON DUKES’ 
STAGING
Group A had a 
significantly greater 
proportion of Dukes’ 
stage D patients 
compared to patients in 
the earlier time period 
(Group B).
Figure 3 —
KAPLAN-MEIER 
ACTUARIAL SURVIVAL 
CURVES – ENTIRE 
SERIES
Kaplan-Meier actuarial 
survival curves 
demonstrating overall 
cumulative survival 
for the entire series 
(Figure a) and between 
groups A and B (Figure 
b). The overall mean 
and median cumulative 
survival was 116 
months and 84 months, 
respectively. One- and 
three-year survival was 
78 and 66%, respectively.
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15 days for gastric cancer, and eight days for bladder 
cancer. Of CRC inpatients, 42% underwent right 
hemicolectomy accounting for the greatest number 
of inpatient procedures (11%).
This study reports a 22-year experience with 422 
cases of surgically-managed colorectal carcinoma 
divided into two time periods, Group A (1980-1991) 
and Group B (1992-2002). There was no difference in 
age, gender, presentation type or type of operation 
performed. Group A however, was more likely 
to have advanced disease at diagnosis, develop 
post-operative complications, and develop local 
recurrence. The 0-day mortality between the two 
groups was not significantly different and the overall 
mean and median survival for both groups also 
did not differ. The incidence of obstructing lesions 
requiring emergency surgery was similar between 
the groups. This suggests that despite improvements 
in perioperative and surgical intensive care, 
emergency admissions of this type continue to be 
major sources of morbidity and mortality. 
Importantly, patients belonging to the earlier time 
period were significantly more likely to present 
with Dukes’ D stage in comparison with patients 
in the later time period (22.2% vs 1.6%, p<0.02), 
demonstrating that patients in the later time period 
had their disease identified at an earlier stage in 
its progression. It is unclear why the groups differ 
in this regard, because age at presentation as well 
as presentation type did not differ significantly, 
but improved patient access and diagnostic 
imaging techniques in the later time period may be 
responsible. McCallion et al reported an apparent 
proximal shift in tumour distribution over a 20-
year period using data collected from all CRC cases 
in the Northern Ireland tumour registry.1 This was 
thought to be due to a rise in the incidence of right-
sided lesions found on colonoscopy and also a rise 
in the aging population who tend to have a greater 
proportion of right-sided lesions. They concluded 
that flexible sigmoidoscopy may lose its importance 
as a screening tool as a result. Our data do not show 
any such change in the tumour distribution; however 
this may be partly explained by the absence of an 
age difference between the two groups.
During the study period a total of 220 operations 
were performed for rectal lesions (52%) and these 
were distributed equally between both groups. 
In our series of patients who underwent anterior 
resections the symptomatic leak rate was 2.%. 
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KAPLAN-MEIER 
ACTUARIAL SURVIVAL 
CURVE – BY DUKES’ 
STAGE
Kaplan-Meier actuarial 
survival curves 
comparing Group A and 
Group B patients by 
Dukes’ staging. 5-year 
survival rates were: 8% 
for Dukes’ A, 74% for 
Dukes’ B, 48% for Dukes’ 
C and 1% for Dukes’ D.
The accepted leak rate in the RCSI guidelines is 
approximately 8% for anterior resections and up to 
15% for low anterior resections.10 Our study compares 
favourably with these and other published studies 
with reported leak rates from % to 21%.14-17 It should 
be noted that routine contrast enemas were not 
used post-operatively, therefore our series does not 
include asymptomatic or sub-clinical leaks. Of the 
50 patients who underwent a low anterior resection, 
six developed a leak (12%). These rates did not differ 
between the two groups. Due to ambiguity in some 
of the medical records on the use of a protective 
stoma versus a therapeutic stoma post leakage, we 
do not have sufficient data to determine whether 
prophylactic stomas may have played a role in the 
low leak rate, however there was no policy of routine 
use in every case.
The local recurrence rate in the series as a whole 
for rectal lesions was 10.5%. After rectal surgery, 
patients in the earlier time period (Group A) 
had a greater local recurrence rate compared to 
Group B patients, but these differences were not 
statistically significant (1.8% vs 7.2%, p=0.17). 
When we compared local recurrence rates after 
anterior resection (AR), Group B was significantly 
lower compared to Group A (. vs 18.0%, p<0.05) 
(Figure 2b). Greater emphasis on surgical technique, 
especially with the introduction of total mesorectal 
excision (TME), which came into widespread usage in 
the late 1980s (including our unit), has been shown 
to lower local recurrence rates.18 In our series, the 
lower recurrence rate after AR in Group B supports 
this. In recent years, more emphasis has been placed 
on the oncological importance of the circumferential 
resection margin and distal mesorectal spread of 
tumour.19 TME is now widely accepted as the optimal 
technique in the resection of rectal cancer,20 and 
the low local recurrence rate and improved survival 
strongly support the necessity to remove the entire 
mesorectum to achieve complete tumour clearance 
in cancers of the middle and lower rectum.21
A total of 77 patients developed complications for an 
overall complication rate of 18%. Group A patients 
developed a significantly greater proportion of 
complications compared to Group B (2.2% vs 1.2%, 
p<0.02), demonstrating a downward trend in the 
incidence of complications for patients in the later 
time period. Twelve patients developed wound 
complications (2.8%), with a greater number in 
Group A (5.4% vs 1.0%, p<0.002). This likely reflects a 
more standardised approach towards perioperative 
antibiotic coverage, as well as improved post-operative 
wound care management in the later time period. 
The overall 0-day mortality rate of 7.1% compares 
favourably with RCSI guidelines and published 
reports.10,22 No significant differences existed between 
the two groups. Twelve out of 55 patients who 
underwent emergency surgery died giving an overall 
emergency operative mortality rate of 21.8%. Slightly 
fewer patients belonged to Group B (five out of 12), 
but the two groups did not differ significantly in this 
regard. The elective operative mortality rate was 4.9% 
and similarly, both groups had comparable mortality 
for elective surgery. When cumulative survival rates 
were examined in overall terms as well as between 
the two groups, patients in the earlier time period 
had similar survival compared to the patients who 
underwent surgery in the later time period (Figure ).
Because of the potential for cure of early-stage 
disease, the definition of populations at risk 
and screening of asymptomatic patients are 
important considerations. Decreases in colorectal 
cancer incidence and mortality rates have been 
largely attributed to the detection and removal of 
precancerous polyps, the early detection of tumours 
through screening, and improved treatments.2,24 A 
prospective, randomised study of faecal occult blood 
suggested that annual tests reduce colorectal cancer-
related deaths by % through 18 years of follow-up.5 
Additional trials have also demonstrated a 15% to 21% 
reduction in colon cancer-related death from biennial 
faecal occult blood testing.25 Examination of the entire 
colon by colonoscopy remains the gold standard for 
visualisation, biopsy, and, when possible, removal 
of colonic neoplasms. The results of the American 
National Polyp Study show that the removal of all 
adenomas in the colon decreases the incidence of 
colorectal cancer by 76% to 90%.8
While our study reflects progress in the treatment 
of colorectal cancer, we conclude that a widespread 
screening programme in Ireland should be 
implemented in order to achieve comparable declines 
for overall death rates, and improved survival rates, 
which would have long term positive effects on the 
burden of costs. Although the most cost-effective 
approach remains to be identified, screening for 
colorectal cancer has the potential to decrease 
mortality by detecting cancers at earlier stages and 
allowing the removal of adenomas, thus preventing 
the subsequent development of cancer. Finally, the 
present series demonstrates that increased attention 
to surgical technique and improvements in surgical 
care over time have led to significant gains in the 
outcome of subsets of patients with colorectal cancer.
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InTRODUCTIOn
In 2002, the North Eastern Health Board (NEHB) 
undertook a study which examined the prevalence 
of smoking, alcohol and drug use among school-
going adolescents in the region.1 As part of this study, 
information on how the adolescents felt about 
themselves using a self-administered depression 
and self-esteem questionnaire was also collected. 
This paper presents the findings and identifies risk 
factors associated with depression and self-esteem 
scores among this cohort. Identification of these 
risk factors in this cohort of young adolescents 
is important given that recent reviews indicate 
that mental health problems in young people are 
increasing and the number of young people taking 
their own lives is rising.2-5 This increase in suicide has 
lead to calls for the identification of young people at 
risk, with a view to the development of prevention 
programmes.4 A recent study in Ireland showed that 
there are large numbers of young people at risk of 
mental health disorders and suicidal ideation and 
raised the question of the importance of mental 
health promotion in the Irish education system.6 
Furthermore, it has been shown that depression in 
adolescents is a strong risk factor associated with 
depression in adulthood and preventive efforts 
should be selectively targeted at adolescents who 
have been exposed to identifiable risk factors.7 The 
aim of this study was to estimate the prevalence 
of self-reported depression and self-esteem among 
school-going adolescents in a geographically defined 
region. A further aim of the study was to identify risk 
factors associated with depression and self-esteem. 
METHODs
A random stratified sampling technique was 
employed to select post-primary schools in counties 
Cavan, Monaghan, Louth and Meath. Of a total 
of 58 post-primary schools, 24 were selected to 
participate in the study. The principal of each school 
was contacted and his or her permission was sought. 
After written consent was received, each school was 
visited and the purpose of the survey was explained. 
Confidentiality was guaranteed and the students 
were made aware that participation in the survey 
was voluntary. Three classes from each school were 
Factors associated with self-reported 
depression and self-esteem among school-
going adolescents from a geographically 
defined region in Ireland
ABsTRACT
Background  Recent reviews indicate that mental health problems in the young are 
increasing.
Aims To measure the prevalence of, and risk factors associated with, depression and low 
self-esteem among Irish post-primary students.
Method  1,428 students, randomly selected from a sample of post-primary schools, were 
given an anonymised questionnaire. Analyses included bivariate and multivariate 
logistic regression. 
Results  Questionnaires were completed by 992 (69.9%) respondents. 206 (20.8%) had 
a high depression score.  Being from a single parent family (OR 2.8, 95% CI 1.5 –5.4, 
p<0.001); having low self esteem (OR 1.44 95% CI 8.9 – 20., p<0.001); being female 
(OR, .7, 95% CI 2.5-5.6 p<0.001) and having a low fitness level (OR 1.8, 95% CI 1.2-2.8 
p<0.006) were independently associated with a high depression score.
Conclusions  The level of self-reported depression was high among these respondents 
and risk factors identified include having low self-esteem, being female, being from 
a single parent family and having a low fitness level.
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then randomly selected to participate. Anonymous 
questionnaires incorporating two standardised 
scales for measuring depressive symptomatology 
(CES-D questionnaire) and self esteem (Rosenberg 
Self-Esteem Scale) were distributed to students 
during a class period by a Research Officer. 
Questionnaires were collected by the Research 
Officer following their completion. Demographic 
data such as age, sex, social class and fitness levels 
were also collected by questionnaire. The completed 
questionnaires were then coded, and analysed 
using JMP statistical analysis package.8 In addition, 
multivariate logistic regression analysis was carried 
out using STATA, version 8.9
Instrument used to measure depression - 
the CES-D scale
The Centre for Epidemiological Studies-Depression 
(CES-D) Scale comprises of a 20-item self-reported 
measure designed to measure symptoms of 
depression.1 The CES-D has been shown to correlate 
substantially with other self-report depression 
measures and to adequately differentiate 
depressed from non-depressed groups.11 The CES-
D has demonstrated its usefulness as a screening 
instrument at both adult and adolescent levels and 
has been successfully used with large adolescent 
school samples.10 Although a score of 16 or more has 
been commonly used in adult samples as indicating 
high levels of depressive symptomatology, Roberts 
et al found that this criterion yielded rates in excess 
of 50% for adolescents, compared with 16-21% for 
general adult population samples.12 Chabrol et al 
found that a higher criterion score of ≥ 24 provided 
a sensibility rating of 0.74 and a specificity rating of 
0.7 when used in adolescents.1 Therefore, for the 
purposes of this study, a CES-D score of ≥ 24 was 
used to demonstrate significant levels of depressive 
symptomatology.
Instrument used to measure self-esteem - 
the Rosenberg Self-Esteem Scale
The Rosenberg Self-Esteem (RSE) Scale is a self-
report measure in which respondents rate their 
agreement with ten statements that describe how 
they feel about themselves. This scale was originally 
developed to measure adolescents’ global feelings 
of self-worth and is generally regarded as being 
the standard against which other measures of self-
esteem are compared. Extensive and acceptable 
reliability (0.82-0.88) and validity data exist for 
the RSE.14
REsULTs
Response rates
Questionnaires were administered to 1,428 students, 
of these, 992 (69.6%) completed the questionnaire 
sufficiently to allow computation of a depression 
and self-esteem score. Given that there were no 
statistically significant differences in demographic 
profile (age, sex and social class profile) between the 
final 992 respondents and the total representative 
sample of 1,428 respondents, this study will 
concentrate on these 992 respondents. 
Demographic profile of respondents
Of the 992 respondents there were significantly 
more males (N=60) than females (N=89), (60.7% 
vs 9.2% p<0.01); the median age was 15 years 
(range 1 to 17 years) and there was no significant 
age difference between the males and females. 
The gender ratio may be explained by the fact that 
among the schools that were randomly selected, 
there was a higher proportion of males than females 
in attendance. Based on their parents’ current 
occupation, a total of 2 (2.6%) belonged to social 
class 1-2(Professional, Managerial/Technical and 
Farmers owning 100 acres of more). In general 
approximately 29.6% of the population of this 
region belongs to social class 1-2.15 However, the 
higher than expected proportion from these groups 
may be explained by the fact that adolescents 
from social classes 1-2 are more likely to attend 
class and therefore had been in attendance to 
complete the questionnaire.16 A total of 7 (7.4%) of 
the respondents reported that they lived in a single 
parent family. Similarly, given that the proportion of 
single parent households with children in Ireland 
is nearer 12%, the lower than expected proportion 
of responders from single parent families may be 
explained by the fact that adolescents from one-
parent families are more likely to miss school more 
often than adolescents from two parent families.15-16
Fitness Levels
The adolescents were asked to rate their fitness on 
a 1-10 scale with 1 equal to ‘Very Unfit’ and 10 equal 
to ‘Very Fit’. A fitness score was completed by 966 
(97.4%) of the respondents. The average fitness score 
recorded by the respondents was 6.2. The average 
fitness score recorded by the male respondents was 
significantly higher than the average fitness score 
recorded by the female respondents (7 vs 5, p<0.001). 
When the fitness scale was dichotomised into ‘low 
fitness level’ (i.e. with a fitness score below the inter-
quartile range) and into ‘high fitness level’ (i.e. with 
a score within and above the inter-quartile range), 
a total of 24 (25.1%) had a low fitness score with a 
significantly higher proportion of females (N=15) 
than males (N=107) among those who had a low 
fitness score (5.4% vs 18.%, p<0.001).
Main Outcome Measures
(a)  CES-D Depression Score
A total of 206 (20.8%) of the respondents had a 
depression score above the cut-off score point 
that indicated that they had significant levels 
of depressive symptomatology on the CES-D. A 
significantly higher proportion of the females, 
152 (9%) than males, 54 (9%) scored a reading 
that indicated that they had significant levels of 
depressive symptomatology (9% vs 9%, p<0.001). 
Table 1 identifies the factors associated with a 
depression score indicative of significant levels 
of depressive symptomatology. As shown, after 
controlling for confounding factors, being female, 
living in a single parent family, having a low self-
esteem score and having a low self-reported 
fitness level were all significantly associated with 
having a depression score indicative of depressive 
symptomatology. Those from a single parent 
family were almost three times more likely to 
have a depression score indicative of depressive 
symptomatology and this was independent of 
age, sex and social class of the respondent. Those 
who had a low self-esteem score were more than 
thirteen times more likely to have a depression 
score indicative of significant levels of depressive 
symptomatology compared to those with a normal/
high self-esteem score. Respondents who reported 
that they had a low fitness level were also almost 
twice as likely to have a depression score above the 
cut off and therefore indicative of significant levels of 
depressive symptomatology compared to those who 
had a high fitness level.
(b) RSE score
The mean RSE score among this cohort of patients 
was 28.9 (S.D. 5.66). The male respondents had a 
statistically significant higher mean self-esteem 
score than the female respondents, (0.5 vs 26.4, 
p<0.001) which indicated that the male respondents 
on average rated their self-esteem higher than the 
female respondents.
Table 1
FACTORS ASSOCIATED wITH A CENTRE FOR EPIDEMIOLOGICAL STUDIES IN DEPRESSION (CES-D) SCORE 
INDICATIVE OF SIGNIFICANT LEVELS OF DEPRESSIVE SYMTOMATOLOGY
VARIABLE CRUDE OR ADJUSTED OR*
P-VALUE FOR 
ADJUSTED OR
Sex (being Female) 6.55 .72 p<0.001
Single Parent Family 2.9 2.86 p<0.001
Low Self-Esteem Score 16.7 1.44 p<0.001
Low Self-Reported Fitness Level 2.68 1.85 p<0.006
* Odds ratios, adjusted for age, social class all other predictive variables above. 
Table 2
FACTORS ASSOCIATED wITH A LOw ROSENBERG SELF-ESTEEM (RSE) SCORE
VARIABLE CRUDE OR ADJUSTED OR*
P-VALUE FOR 
ADJUSTED OR
Sex (being female) 4.57 2.4 p<0.001
Single Parent Family 1.74 0.8 p=0.59
High CES-D score indicative of 
significant levels of depression
16.7 1.7 p<0.001
Low Self-Reported Fitness Level 2.0 1.20 p=0.9
*Odds ratios, adjusted for age, social class all other predictive variables above. 
FACTORS ASSOCIATED wITH SELF-REPORTED DEPRESSION AND SELF-ESTEEM AMONG SCHOOL- 
GOING ADOLESCENTS FROM A GEOGRAPHICALLY DEFINED REGION IN IRELAND
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When the self-esteem score was dichotomised 
into ‘low self-esteem’ (i.e. with a self-esteem score 
below the inter-quartile range) and into ‘normal/
high self-esteem score (i.e. with a score within and 
above the inter-quartile range), a total of 215 (21.6%) 
had a low self-esteem score. A significantly higher 
proportion of the females than males had a ‘low’ RSE 
score (7.5% vs 11.6%, p<0.0001). As shown in Table 2 
when the factors previously identified as associated 
with a high depression score were placed in the 
model to identify factors associated with a ‘low self-
esteem score’, only being female and having a high 
depression score remained significant factors after 
controlling for the other factors in the model. This 
suggests that although being from a single parent 
family was independently associated with having 
a high depression score, it was not independently 
associated with a low self-esteem score. Furthermore 
whilst a low fitness score was independently 
associated with a high depression score, a low fitness 
score was not independently associated with self-
esteem score.
DIsCUssIOn
The CES-D questionnaire was used to determine 
self-reported depression among this cohort of 
students. Over 20% of the respondents had a 
depression score above the cut-off point and 
therefore indicative of significant levels of depressive 
symptomatology. This finding is very similar to the 
findings by Lawlor and James which showed, using 
the Youth Self-Report questionnaire, that 21.% of 
a sample Irish 16-year-olds attending post-primary 
school have psychological problems17. Females 
had a higher average depression score than the 
males with a significantly higher proportion of the 
females compared to the males having a CES-D 
reading indicating significant levels of depressive 
symptomatology and this is in keeping with 
international studies on self-reported depression 
among adolescents which show a higher prevalence 
of self-reported depression among female 
adolescents.18,19 It is very interesting to note that 
several factors other than sex were independently 
associated with depression scores among this 
cohort of students. These factors included living in 
a single parent family whereby those adolescents 
who lived in a single parent family were almost 
three times more likely to have a higher depression 
score than those adolescents who lived in a two-
parent family. This finding is supported by other 
international studies, which show that parental 
separation increases the risk of adolescent mental 
health problems.20 Census results from 1996 and 
2002 show that between 1996 and 2002, the 
number of households containing a lone parent 
with children increased by 24.5%14. This increasing 
rate of marital breakdown in Ireland has therefore, 
serious implications for the mental health of our 
adolescents. Family support measures in Ireland need 
to be enhanced if the trend in family breakdown is to 
be reversed. As some of the risk factors for adolescent 
mental health are outside the sphere of health 
services, a public health approach, which involves 
other agencies of the state is required to reduce 
the burden of mental health illness in adolescents. 
Given that a previous follow-up study on the risk for 
depression in Finnish adolescents6 showed that self-
reported perceptions of psychosocial well-being have 
predictive value and therefore, it seems reasonable to 
suggest that preventive efforts should be selectively 
targeted at adolescents who have been exposed to 
identifiable risk factors. An Irish study by James and 
Lawlor21 on early school leavers showed that 24% 
of early school leavers experienced psychological 
problems and recommended that this vulnerable 
group be provided with psychological support and 
treatment if necessary. However, our study suggests 
that the psychological support and treatment 
should be made available before the adolescents 
leave school and perhaps in the school setting since 
the prevalence of high depression scores is evident 
before these adolescents leave the school setting. 
The Rosenberg Self-Esteem questionnaire was 
used to measure self-esteem among this cohort 
of students and it was found that the mean self-
esteem score for the males and for the females in 
this study were broadly in keeping with a national 
study carried out by Nic Gabhainn and Mullan on 
the self-esteem norms for young (aged 10-17) Irish 
people.22 Similarly to this study, it was found that the 
females on average, had a lower self esteem score 
than the males. When the data were categorised 
into low self-esteem and normal/high self-esteem, it 
was found that over a fifth (21%) of the adolescents 
reported a low self-esteem score. When multivariate 
analysis was carried out it was also found that, after 
controlling for other factors, such as age, sex, and 
social class, self-reported depression was the only 
factor independently associated with self-esteem. 
Those adolescents with a high depression score had 
a lower self-esteem score than those with a low 
depression score and this was particularly evident 
among the female adolescents.
It was also interesting to note that when asked 
about self-reported fitness level the majority of the 
adolescents rated their fitness level reasonably high 
(i.e. an average of 6.2 on a 1-10 continuous scale). 
However, a significant minority of the respondents 
(25%) had a ‘low fitness level’. It is interesting to 
note that a low self-reported fitness level was one 
of the factors that was positively correlated with a 
high depression score whereby those who had a low 
self-reported fitness level were almost twice as likely 
to report a high depression score. This finding is not 
surprising given that a substantial body of literature 
attests to the benefits associated with fitness and 
psychological health.2 Therefore, health promotion 
strategies to encourage fitness levels and exercise 
among adolescents may have a beneficial effect 
on the psychological health as well as the physical 
health of adolescents. Previous studies involving 
adolescents have shown that an important predictor 
of physical activity behaviour was participation 
in community sports.24 Therefore perhaps one 
potentially effective way to increase physical activity 
among these adolescents would be to facilitate 
greater access to community-based physical activity 
outlets such as fitness programmes designed 
specifically for adolescents. To help with this process, 
schools could establish links with community sports 
leaders so that students become more aware of the 
physical activity opportunities in their community. 
LIMITATIOns Of THE sTUDy
This study was a cross-sectional study and therefore 
a causal relationship between risk factors and 
outcome measures can only be inferred. Data on 
confounding factors such as timing of parental 
separation25 and parental depression26 that may 
be associated with both single parent families and 
depression are lacking in this study. However, the 
finding that the high depression scores are highest 
among adolescents from single parent families 
compared to adolescents from two parent families 
is consistent with both Irish6 and international 
studies.20 This study used self-administered 
questionnaires to measure depression and self-
esteem and therefore, the findings may not be as 
reliable as that information obtained by interview or 
clinical assessment. However, self-report measures 
are found to be reliable with adolescents27 and our 
findings are similar to previous studies suggesting 
that it is likely that our measures of depression and 
self-esteem are reliable. 
COnCLUsIOn
To conclude, this study has shown that the 
prevalence of self-reported depression as measured 
by CES-D scale is high among this cohort of 
adolescents with greater than 1 in 5 of the 
respondents reporting a high CES-D depression 
score (i.e. over the cut-off point that is indicative of 
significant levels of symptomatology). Moreover, a 
high CES-D depression score was associated with 
being female, being from a single parent family, 
having a low self-reported fitness level and low 
self-esteem score. This paper has also shown that 
the average self-reported self-esteem score of the 
male and female adolescent responders in this 
study are similar to those found in a larger Irish 
study with over 21% of the respondents reporting to 
have a ‘low self-esteem score’. Given that the risk of 
depression in adulthood is strongly associated with 
depression in adolescence, it is of great importance 
that preventive efforts are selectively targeted at 
those adolescents who are exposed to those risk 
factors associated with a high depression score, such 
as being from a one-parent family and having a low 
self-reported fitness levels. Effective mental health 
promotion strategies should be included as part of 
the school curriculum. 
REFERENCES
1. Flanagan E, Bedford D, O’Farrell A, Browne C, Howell 
F. Smoking, Alcohol & Illicit Drug Use among Young 
People in a Health Board Region in 1997 and 2002: A 
Comparative Study. Irish Med. Journal,(2004), Sept, 97(8): 
20-24.
2. Fombonne E. Increased rates of Psychosocial disorders 
in youth. Eur. Arch. Psychiatry Clin. Neuosci., 1998, 248: 
14-21.
. Smith D, Rutter M. Time trends in psychosocial disorders 
of youth. In: Psychosocial disorders in young people: time 
trends and their causes. (Rutter, M and Smith D, eds.). 
John Wiley & Sons, Chichester, UK, 1996.
4. Department of Public Health, Health Boards. Suicide in 
Ireland: A national study. Dublin: Departments of Public 
Health on Behalf of the Chief Executive Officers of the 
Health Boards, 2001. 
5.  Anderson M. Waiting for harm: Deliberate self-harm 
and suicide in young people – a review of the literature. 
J. of Psychiatric & Mental Health Nursing, 1999, 6: 91-
100.
6. Lynch F, Mills C, Daly I, Fitzpatrick C. Challenging times: 
a study to detect Irish adolescents at risk of psychiatric 
disorders and suicidal ideation. J. of Adolescence, 2004, 
27: 441-451.
FACTORS ASSOCIATED wITH SELF-REPORTED DEPRESSION AND SELF-ESTEEM AMONG SCHOOL- 
GOING ADOLESCENTS FROM A GEOGRAPHICALLY DEFINED REGION IN IRELAND
A O’FARRELL ET AL
24 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4
O
R
IG
IN
A
L 
PA
P
E
R
O
R
IG
IN
A
L 
PA
P
E
R
IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4  25
7. Pelkonen M., Marttunen M, Aro H. Risk for depression: 
a six-year follow-up of Finnish adolescents. J. Affect 
Disord., 200, Oct. 77(1): 41-51.
8. SAS Institute Inc. JMP Statistical Package. Version 5, Cary 
NC, USA, 2002.
9. Stata Corporation. STATA statistical software: release 8.0, 
College Station, TX: Stata Corporation, 1999. 
10. Radloff S. The CES-D scale: a self-report scale for 
research in the general population. Applied Psychol. 
Measurement,1977, 1: 85-401.
11. Garrison CZ, Schluchter MD, Schoenbach VJ, Kaplan 
BK. Epidemiology of depressive symptoms in young 
adolescents. Journal of the Amer. Acad. of Child & 
Adolescent Psych.,1989, 28(), 4-51.
12. Roberts RE, Andrews JA, Lewinsohn PM, Hops H. (1990). 
Assessment of depression in adolescents using the 
Centre for Epidemiologic Studies Depression Scale. 
Psychol. Assessment,1990, 2(2): 122-128.
1. Chabrol H, Montovany A., Chouicha K, Duconge E. Study 
of the CES-D on a sample of 195 adolescent students. 
Encephale, 2002, 28(5): 429-42.
14. Blascovich, J, Tomaka, J. Measures of Self-Esteem. 
In: Measures of Personality and Social Psychological 
Attitudes (rd Ed). J.P. Robinson, P.R. Shaver & L.S. 
Wrightsman (Eds), Ann Arbor: Institute for Social 
Research, 199.
15. Census Population 2002. Household composition 
and family units. Volume . Central Statistics Office of 
Ireland. Stationery Office, Dublin, August 200. 
16. Kinder K, Harland J, Wilkin A, Wakefield A. Three to 
remember: strategies for disaffected pupils. National 
Foundation for Educational Research, Slough, U.K, 1995. 
17.  Lawlor M, James D. Prevalence of psychological 
problems in Irish School going adolescents. Irish J. 
Psychol. Med., 2000, 17(4): 117-122.
18. Lagges AM, Dunn DW. Depression in children and 
adolescents. Neurol. Clin. 200 Nov;21(4):95-60.
19. Birmaher B, Ryan ND, Williamson DE et al. Childhood 
and adolescent depression: a review of the last 10 
years. Part 1. J. Am. Acad Child Adolesc Psychiatry. 1996 
Dec;5(12): 1427-149.
20. Fergusson DM, Horwood LJ, Lynskey MT. Parental 
separation, adolescent psychopathology, and problem 
behaviours. J. Am. Acad. Child. Adolesc. Psychiatry. 1994 
Oct;(8):1122-1 
21. James D, Lawlor M. Psychological problems of early 
school leavers. Ir. J. Psych. Med. (2001). 18(2): 61-65.
22. Nic Gabhainn S, Mullan E. Self-esteem norms for Irish 
young people. Psychol. Reports, 200, 92: 829-80.
2. Byrne A, Byrne DG. The effect of exercise on depression, 
anxiety and other mood states: a review. J. Psychosom. 
Res., 199, 27(6): 565-574.
24. Trost SG, Pate RR, Saunders R, Ward DS, Dowda M, Felton 
G. A prospective study of the determinants of physical 
activity in rural fifth-grade children. Prev. Med., 1997 
Mar-Apr;26(2):257-6.
25. Palosaari U, Aro H. Effect of timing of parental divorce 
on the vulnerability of children to depression in young 
adulthood.  Adolescence, 1994. 29(115): 681-690.
26. Tan S, Rey J. Depression in the young, parental 
depression and parenting stress. Australas. Psychiatry, 
2005 Mar;1(1):76-9.
27. Place M. The relative value of screening instruments in 
adolescence. J. of Adolescence, 1987, 10: 227-240.
Correspondence to: Anne O’Farrell
Dept of Public Health, Health Service Executive-North 
Eastern Area, Railway Street, Navan, Co. Meath
Tel: 046 90 76492   Email: ann.o’farrell@maile.hse.ie
InTRODUCTIOn
Paediatric trauma is a major health problem 
affecting children over one year of age. Multiple 
reports indicate that serious trauma in the paediatric 
age group will remain a continuing problem in the 
future.1 In the United States of America (USA) it has 
been suggested that all severely injured children 
should be managed in regional paediatric trauma 
centres to ensure best possible care and outcome.2 
The British Association of Paediatric Surgeons (BAPS) 
recommends that a specialist paediatric surgical 
unit consisting of four specialist paediatric surgeons 
and one paediatric urologist should cater for the 
specialist paediatric needs of a population of 2.5 
million and the general paediatric surgical needs of 
1.2 million. In the Republic of Ireland the number 
of specialist paediatric surgeon posts fall short of 
this recommendation with the result that specialist 
paediatric surgical services for the country are based 
primarily in Dublin. Elsewhere most paediatric 
general surgery and much specialist paediatric 
surgery e.g. urology, is performed by general and 
other surgeons with paediatric training as defined by 
the Senate of Surgery of Great Britain and Ireland.4 
Many seriously injured children are cared for by 
general surgeons in general hospitals which deal 
with both adult and paediatric trauma.
The Mid-Western Regional Hospital, Limerick is the 
largest hospital in the HSE Mid-Western area, which 
consists of the counties of Limerick, Clare and North 
Tipperary. This area has a population of 9,591 
with 71,968 (21%) under the age of 14 years (2002 
population census, CSO).5 Three general surgeons 
and one urologist, all with paediatric training 
provide general paediatric surgery and paediatric 
urology services in the Mid-Western Regional 
hospital for this HSE area. These consultants work in 
collaboration with twelve consultant anaesthetists 
and six consultant radiologists, all with paediatric 
experience, and five consultant paediatricians. 
Paediatric surgical admissions are cared for in 
a dedicated paediatric unit staffed by trained 
paediatric nurses and also in a surgical day unit. 
The adult intensive care unit is used for paediatric 
admissions when necessary as there is no dedicated 
paediatric intensive care or high dependency unit. 
METHODs
We carried out a retrospective audit of all paediatric 
trauma patients admitted to our institution between 
January 2000 and December 2001. Inclusion criteria 
were that the patients were less than 14 years of 
age and admission was as a result of accidental 
injury. Children with orthopaedic trauma alone were 
excluded from this study; this accounted for 629 
admissions.
Patients’ charts were reviewed for demographic 
data and information related to mode of injury, 
investigations, treatments and outcomes. The injury 
severity score (ISS) and the revised trauma score 
Non-orthopaedic paediatric trauma in a 
regional hospital
ABsTRACT
Background  In the Republic of Ireland there are no paediatric surgeons outside Dublin. Most 
paediatric trauma is managed in general hospitals by general or orthopaedic surgeons.
Aim In this study we audited our experience with paediatric trauma in a regional setting. 
Methods  We carried out a retrospective review of all non-orthopaedic paediatric trauma 
patients admitted to our institution over a two-year period. The method of injury, 
management and outcome were recorded and the TRISS (revised trauma injury 
severity score) method was used to calculate the probability of survival.
Results  One hundred and fifty four paediatric patients were admitted following trauma. 
Falls, RTAs and burns were the commonest reasons for admission. Twenty nine of 
these patients (19%) required surgical procedures. There were no unexpected deaths.
Conclusion  The majority of paediatric trauma admissions were for minor injuries. A number 
of seriously injured children were successfully treated with no unexpected deaths.
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(RTS) were calculated. The ISS, first introduced by 
Baker et al in 1974, is derived from the abbreviated 
injury scale (AIS) which is a numerical method 
for grading injuries by severity on an ordinal scale 
ranging from 1 (minor injury) to 6 (maximum injury).6 
The ISS is used to summarise multiple injuries in 
a single patient. The ISS is defined as the sum of 
squares of the highest AIS grade in the three most 
severely injured body regions. Six body regions are 
defined; the thorax, abdomen and visceral pelvis, 
head and neck, face, bony pelvis and extremities, 
and external structures. ISS ranges from 1-75. If an 
injury is assigned an AIS of 6 (unsurvivable injury), 
the ISS is automatically assigned to 75. The RTS, is 
a physiological scoring system which uses three 
specific physiologic parameters; the Glasgow Coma 
Scale, systemic blood pressure, and the respiratory 
rate. Parameters are coded from 0-4 based on the 
magnitude of the physiologic derangement.7 RTS 
is determined by adding each of the coded values 
together. RTS range from 0-12.7
The TRISS method was used to calculate the 
probability of survival (Ps) among these patients.8 
This test combines both anatomic and physiologic 
measures of injury severity (ISS and RTS, respectively) 
and patient age in order to predict survival from 
trauma. This method recognises the difference 
between blunt and penetrating injury. The logistic 
regression equation predicts the probability of survival.
The observed and expected survivals were compared 
using Z statistics, which quantify the difference in 
the actual number of deaths (or survivors) in the 
test subset, and the predicted number of deaths 
(or survivors) based on the baseline norm from the 
American Major Trauma Outcome Study (MTOS).8,9
REsULTs
One hundred and fifty four paediatric patients (96 
male, 58 female), were admitted with trauma during 
the two-year period. The median age was four years 
(range 2 months-14 years). Falls were the commonest 
cause of injury, accounting for 56.4% of all 
admissions, this was followed by injuries sustained 
in road traffic accidents (RTAs) which accounted 
for 21.4% (n=) of admissions, burns 9.7% (n=15), 
gunshot injuries 1.9% (n=) and miscellaneous 
injuries 10.% (n=16) (Figure 1). There were four 
pedestrian injuries out of  RTAs.
One hundred and three patients had either a 
primary or secondary diagnosis of head injury. 
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Median Glasgow Coma Score (GCS) was 7.5 (range 
-15). Thirty-six patients (2.4%) had a computerised 
tomography (CT) brain scan; only one of whom 
had a GCS of less than ten. Eight scans had positive 
findings, three patients had an extradural haematoma 
(EDH), two had skull fractures, two had oedema with 
contusion and one patient had a severe intracerebral 
haemorrhage, this patient subsequently died. 
Mean ISS was 11 (±6.6,SEM) (Figure 2). Twenty nine 
patients (19%) required 0 surgical procedures: 
wound exploration n=21 (14%), exploratory 
laparotomy n=5 (%), chest drain insertion n= (2%), 
and scrotal exploration n=1 (0.6%). Fourteen patients 
with suspected serious blunt abdominal trauma 
had radiological imaging; CT scan was performed 
in six patients and abdominal ultrasound in eight. 
One patient had a positive diagnostic peritoneal 
lavage (DPL) and underwent a laparotomy on 
the basis of the DPL findings. Only four of the 14 
patients who had an abdominal scan required an 
exploratory laparotomy. The other 10 were managed 
conservatively.
Seventeen patients (11%) were referred to specialist 
units: 1 (8.4%) to plastic surgery,  (1.9%) to 
neurosurgery and 1 (0.64%) to a spinal unit. There 
was one death (0.6%) due to a severe head injury. 
The majority of admissions were for minor trauma. 
There were no unexpected deaths in our study but 
there were four unexpected survivors (probability 
of survival score<0.5). Of the unexpected survivors 
two patients suffered from blunt trauma injuries, 
one resulted in a head injury, skull fracture, bilateral 
pneumothorax and liver haematoma, the other 
patient with a duodenal perforation. The other 
two unexpected survivors were injured in RTAs, 
one patient sustained a mesenteric tear, jejunal 
perforation and wound dehiscence requiring a 
second laparotomy, the other RTA patient sustained 
liver and spleenic lacerations, fractured C-4 and 
a head injury. Applying TRISS methodology from 
the major trauma outcome study the Z statistic for 
survival in our study was 0.12 (p>0.5).
DIsCUssIOn
The care of injured children begins with the 
understanding that they have special needs. Children 
can compensate better following haemorrhage 
than adults but pose problems in management 
due to their small size and other unique anatomic 
features.10 
In the ideal world all paediatric trauma cases would 
be admitted to a specifically designated paediatric 
centre, however in most countries this is not feasible. 
In the USA there has been considerable concern 
about the issue of adult trauma centres looking 
after the paediatric trauma patients. However, even 
in the USA it is not logistically possible to have 
paediatric trauma centres for children in every state 
and most paediatric trauma patients are treated by 
adult general and trauma surgeons.11 The situation 
is similar in the UK and Ireland where specialist 
paediatric surgeons provide specialist services 
in neonatal and complicated paediatric surgery, 
but a large percentage of paediatric trauma cases 
are treated in regional centres. In the Republic of 
Ireland (population 4 million) there are only four 
specialist paediatric surgeons, three less than the 
number recommended by the British Association of 
Paediatric Surgeons (BAPS). BAPS also recommends 
that non-specialist or general paediatric surgery can 
be provided safely by appropriately trained general 
surgeons in hospitals that serve a population of 
200,000 or more. The Senate of Surgery of Great 
Britain and Ireland has recommended that non-
specialist or general paediatric surgery may be 
undertaken by a general surgeon who has received 
appropriate training and that this surgeon would be 
known as a general paediatric surgeon.4 
A review of the literature published on survival 
of paediatric trauma cases treated in dedicated 
paediatric centres compared to regional centres 
with paediatric commitment shows mixed results. 
Various studies reported greater survival rates in 
designated paediatric centres,12,1,14 when compared 
to regional centres, yet other studies have reported 
comparable rates.15,16 For example Osler et al, in 2001 
compared 55,11 paediatric trauma cases from 22 
dedicated paediatric trauma centres and 1 adult 
trauma centres.15 They reported lower mortality 
rates in those treated in the designated centres, 
yet discovered that patients admitted to the adult 
trauma centres were more severely injured. When 
the analysis controlled for injury severity score, 
paediatric trauma score, age and mechanism of 
injury and when The American College of Surgeons 
verification status was applied the difference was 
eliminated and comparable mortality rates were 
reported. The results from these published studies 
highlight the importance of developing a detailed 
national paediatric trauma registry. In Ireland such a 
registry would allow for comparison of results from 
different centres, allowing for future planning and 
development of paediatric services. 
For this study we used TRISS methodology to evaluate 
the outcome of paediatric trauma patients presenting 
to our hospital. It has been proven in previous 
studies by Eichelberger17 and Kaufmann18 that TRISS 
methodology is applicable to children and provides a 
reliable method of predicting outcome and evaluating 
quality, comparable to an adult population. In our 
study most of the children were in the minor trauma 
group, however there were 24 children with an ISS 
score of more than 20 indicating severe injury. We did 
not encounter any unexpected deaths in our group. 
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Conversely, there were four unexpected survivors with 
probabilities of survival of less than 0.5. There was only 
one death; this patient had a serious head injury with 
a GCS of three on arrival.
In our study group falls were the commonest cause 
of injury accounting for 57% of cases followed by 
RTAs (21.4%). These figures are consistent with the 
published findings from other centres.19,20 When the 
different age groups were compared falls were the 
commonest cause of injury in preschool children 
and RTAs were more prevalent in children older 
than five years of age (Figure ). Head injury was 
the commonest reason for admission. In this study 
group, the threshold for CT scanning children with 
head trauma was quite low; only one patient had a 
GCS of less than 10. Interestingly this policy of low 
threshold for CT brain scanning seems worthwhile as 
eight scans were positive for intracranial injury. This 
policy of low threshold for brain CTs is consistent 
with the NICE guidelines for the management of 
head injury in children.21
The positive patient outcomes seen in this small 
study group reflects the paediatric training 
experience of the various consultants involved in 
the management of these children. To maintain 
paediatric competence in the regions in Ireland there 
is a need to include rotations in paediatrics in the 
higher training curricula of the various disciplines 
involved, especially general surgery. 
Another issue for debate in centres without 
paediatric surgeons is whether injured children 
should be under the direct care of paediatric 
physicians or general surgeons. We agree with the 
opinion of Knudson et al that the care of injured 
children should remain the responsibility of surgical 
teams for optimum outcome.2 Appropriately trained 
surgeons not only have the knowledge and skills 
to adequately resuscitate the patient but also are 
the most appropriate clinicians to decide which 
patient may need surgical intervention. The decision 
to treat an injured patient conservatively requires 
the judgement of an experienced surgeon who is 
capable of intervention should his or her decision 
prove wrong. Ten of the fourteen patients with 
blunt abdominal injuries and positive scans (free 
intraperitoneal fluid) were successfully managed 
conservatively. In our study 19% of patients required 
some sort of surgical intervention and three were 
transferred to neurosurgeons, two of these required 
neurosurgical intervention.
COnCLUsIOn
The purpose of our study was to evaluate the 
morbidity and mortality of trauma patients in the 
paediatric age group admitted to our hospital. 
Although the majority of patients had suffered 
minor trauma, the outcome of severely injured 
children was favourable with no unexpected 
mortalities. Appropriately trained general surgeons 
with experience in paediatric surgery can safely care 
for injured children in regional hospitals that have 
considerable paediatric infrastructure. We suggest 
that a rotation in paediatric surgery should be 
mandatory in the higher surgical training curriculum 
to enable the next generation of regional surgeons to 
continue to look after injured children. In addition a 
national paediatric trauma registry would allow for 
continuing audit of practices and outcomes.
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InTRODUCTIOn
Ulcerative colitis (UC) and Crohn’s disease (CD) are 
chronic spontaneously relapsing and remitting 
diseases requiring both frequent attendance at 
hospital and hospital admissions. They pose a 
considerable burden on health resources globally 
and have a significantly negative impact on the 
quality of life of the patients affected. In recent years, 
there has been a global increase in the reported 
incidence of IBD.1- In addition, novel treatments have 
been introduced to the management repertoire 
for patients with IBD, some requiring day-case 
admission. In particular, with the introduction of 
biological therapy in the form of Infliximab, the 
management of patients with Crohn’s disease has 
moved increasingly towards day-case treatment. 
Bearing these factors in mind, the aim of our study 
was to assess the pattern of admission and outcome 
for patients with IBD between 1996 and 2001 in 
Ireland. We also aimed to assess the admission rates 
and outcome for patients with IBD in our unit during 
this five-year interval. 
METHODs
To carry out this study, national data were obtained 
from the Economic and Social Research Institute 
(ESRI), where all data from the local HIPE (Hospital In-
Patient Enquiry) schemes are accumulated. HIPE is a 
computer-based health information system designed 
to collect clinical and administrative data regarding 
discharges and deaths from acute public hospitals. 
The coding scheme used to identify diagnoses and 
surgical procedures is the International Classification 
of Diseases - 9th Revision - Clinical Modification, 
known as ICD-9-CM. In Ireland, 60 acute public 
hospitals participate in HIPE. Maternity hospitals 
are beginning to participate as well as some private 
hospitals. HIPE national coverage varies considerably 
since data collection began in 1970. Coverage is now 
over 95% since 1995. HIPE statistics identifies single 
and repeated admissions for individual patients.
REsULTs
A) National data
In Ireland, between 1996 and 2001, the total number 
of admissions per year (in-patients and day-case) for
Increasing rates and changing patterns of 
hospital admissions for patients with inflam-
matory bowel disease in Ireland: 1996 – 2001
ABsTRACT 
Background  The inflammatory bowel diseases require frequent hospital visits. The 
literature suggests that the incidence of IBD may be increasing. 
Aim To investigate the pattern of admissions of patients with inflammatory bowel 
disease (IBD) to hospital over a five-year period (between 1996 and 2001). 
Methods  We obtained national data regarding admission rates for patients with IBD 
from the Economic and Social Research Institute (ESRI) during the years 1996 and 
2001. Local data were gathered from the Hospital In-Patient Enquiry (HIPE) scheme 
for the same years. 
Results  Over this five-year period, there has been a substantial increase in the rate of 
admission with IBD (58% for Crohn‘s disease and 25% for ulcerative colitis), in 
particular in the number of day-case admissions for patients with Crohn’s disease 
(125%). There has been little change in the number of patients undergoing surgery 
for their disease (Crohn’s disease; 24% vs 20% and Ulcerative colitis; 17% vs 16.6%) 
and in the length of hospital stay. 
Conclusion  Despite an increase in the rate of admission with IBD, there has been little 
change in the rates of surgical intervention and length of stay. The most dramatic 
increase was seen in the day-case admissions for patients with Crohn’s disease and 
may reflect the use of anti-TNFα (infliximab) in the treatment of this disease.
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patients with Crohn’s disease increased from 1077 to 
1706, an increase of 58%. During the same interval, 
the total number of admissions for ulcerative colitis 
increased from 157 to 1922, a 25% increase (Figure 1). 
In 1996, ulcerative colitis resulted in more admissions 
than Crohn’s disease (157 vs 1077). However, these 
numbers have approximated in 2001 (1922 vs 1706).
For Crohn’s disease, the total number of in-patient 
admissions increased by 1%, from 762 to 998. 
Interestingly, there was a marked increase of 125% in 
the total number of day-case admissions for these 
patients, from 15 to 708 (Figure 2). We evaluated 
the proportion of patients with Crohn’s disease 
who underwent a major surgical procedure during 
admission to hospital. The surgical procedures 
included colonic resections, fistula and stomal 
surgery. There has been little change in the number 
of patients requiring surgery for Crohn’s disease. In 
1996, 179 of 762 admissions (24%) required surgery 
compared to 200 out of a total of 998 (20%) in 2001.
For ulcerative colitis, the total number of in-patient 
admissions increased by 22% from 709 to 862. The 
number of day-case admissions increased by 28% 
from 828 to 1060 (Figure 2). This increase in day-case 
admissions is considerably less than that observed 
for those with Crohn’s disease. We evaluated the 
proportion of patients with ulcerative colitis who 
underwent a major surgical procedure during 
hospital admission. In 1996, 121 patients out of a 
total of 709 (17.1%) in-patients with ulcerative colitis 
required surgery compared to 14 of 862 (16.6%) 
in 2001. The surgical procedures included colonic 
resections and stomal surgery. 
B) Data from Beaumont hospital
Beaumont Hospital is a 629-bed teaching hospital 
and a tertiary referral center for patients with 
gastrointestinal disease. The trends for patients 
with IBD in Beaumont Hospital were similar to 
the national trends above. The total number of 
admissions to Beaumont Hospital for patients with 
Crohn’s disease has increased from 8 to 144 (279%) 
between 1996 and 2001. For ulcerative colitis, the 
numbers have increased from 6 to 142 (125%) during 
the same five-year period (Figure ). Interestingly, 
there was a substantial difference in the number 
of admissions for Crohn’s disease compared to 
ulcerative colitis in 1996 (8 vs 6). Again these 
figures have approximated in 2001 (144 vs 142).
Within the group of patients with Crohn’s disease, 
the number of in-patient admissions increased from 
2 to 55, a 19% increase. However, regarding day case 
admissions there has been a dramatic 49% increase 
from 15 to 89 within the same timeframe (Figure 4). 
The number of patients undergoing surgery has 
changed little during this time despite an increase 
in the number of admissions. In 1996, eight of the 2 
in-patients underwent surgery for Crohn’s disease 
compared to 10 of 55 patients in 2001. The surgical 
procedures included colonic resections, fistula 
surgery and stomal revisions.
For ulcerative colitis, there has been a 119% increase 
in the number of in-patient admissions between 
1996 and 2001, 21 to 46. The number of day-case 
admissions for ulcerative colitis increased by 129%, 
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Figure 1: This graph shows the overall number of 
admission for patients Crohn’s disease and ulcerative 
colitis in Ireland, in the years 1996 and 2001.  The graph 
includes in-patient and day-case admissions.
N
O
. O
F 
A
D
M
IS
SI
O
N
S 
/ 
YE
A
R
1996 2001
1000
500
0
In-
patients
Day-
cases
In-
patients
Day-
cases
CROHN'S DISEASE ULCERATIVE COLITIS
Figure 2 —
TOTAL NUMBER OF 
ADMISSIONS FOR 
PATIENTS wITH 
CROHN’S DISEASE 
AND ULCERATIVE 
COLITIS IN IRELAND: 
IN-PATIENTS AND DAY 
CASES
Figure 2: This graph shows the total number of 
admissions for patients with Crohn’s disease and 
ulcerative colitis in Ireland, in the years 1996 and 2001. 
The graph specifically distinguishes between in-patient 
and day-case admissions for the patient groups in 
each year.
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from 42 admissions to 96, (Figure 4). In 1996, nine of 
the 21 in-patients with ulcerative colitis underwent 
surgery compared to 15 of 46 in 2001. The surgical 
procedures included colonic resections and stomal 
surgery.
In Ireland, the average length of stay has remained 
at 11 days for patients with Crohn’s disease and has 
reduced marginally from 12 to 11 days for patients 
with ulcerative colitis. In our institution, the average 
length of stay for patients with Crohn’s disease has 
reduced from 14 to 1 days and from 22 to 18 days for 
patients with ulcerative colitis.
C) Results of audit from Beaumont Hospital, 2001
During 2001, 92 patients were admitted as 
in-patients to Beaumont Hospital for further 
management for their inflammatory bowel disease. 
Forty-five patients had Crohn’s disease, 5 had 
ulcerative colitis and two had indeterminate colitis.
Of the 45 patients with Crohn’s disease, 44 had 
ileocolitis, colitis or a combination of both with 
one patient having gastric Crohn’s disease. Sixteen 
patients underwent surgery during their admission 
(seven elective, nine emergency), 50% of whom 
required surgery for either stricturing or fistulating 
disease. Seventy five per cent had a bowel resection 
of some type (Table 1).
Thirty-five patients were admitted with ulcerative 
colitis, the majority of whom had either left-sided 
disease or pancolitis. Fifteen of these patients 
underwent surgery, seven on an elective basis and 
eight as an emergency. The commonest indication 
for surgery was failure of medical therapy. The 
commonest surgical procedure was a total colectomy 
(Table 2).
DIsCUssIOn
The results of this study illustrate several points 
regarding the pattern of admission to hospital of 
patients with IBD in recent years. Overall, there has 
been an increased rate of admission during the 
relatively short time interval of this study. Despite 
this increase, there has been little change in the 
number of patients requiring surgery for their 
disease. There has been a reduction of four days 
in the length of stay for patients with ulcerative 
colitis in our institution but overall little change in 
the average length of stay for patients with IBD in 
Ireland. In addition, there has been a considerable 
increase in the number of day-case admissions, in 
particular related to patients with Crohn’s disease. 
These observations however must be taken in the 
context that they depend completely on the accurate 
and complete documentation and collection of data 
for the HIPE system. We know however that over 95% 
coverage is estimated since 1995 in the HIPE system. 
One potential reason for these trends is an increase 
in the incidence and prevalence of IBD globally and 
this has been supported in the literature over the last 
decade. Many studies have been carried out across 
Europe and the United States over the last number 
of years suggesting an increase in the incidence of 
IBD. A review from Sweden supports this increase 
during the past decades and quotes a prevalence of 
0.5% in the northern part of the world at present.1  
Figure 3 —
TOTAL NUMBER OF IN-
PATIENTS AND DAY-
CASE ADMISSIONS 
FOR PATIENTS wITH 
INFLAMMATORY 
BOwEL DISEASE 
IN BEAUMONT 
HOSPITAL: 1996 - 2001
CROHN'S
DISEASE
ULCERATIVE
COLITIS
N
O
. O
F 
A
D
M
IS
SI
O
N
S 
PE
R 
YE
A
R
0
50
100
150 1996
2001
This graph shows the overall number of admissions 
for patients with Crohn’s disease and ulcerative colitis 
in Beaumont hospital, in the years 1996 and 2001. The 
graph includes in-patient and day-case admissions.
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This graph shows the total number of admissions for 
patients with Crohn’s disease and ulcerative colitis in 
Beaumont hospital, in the years 1996 and 2001. The 
graph specifically distinguishes between in-patient and 
day-case admissions for the patient groups in each year.
Armitage et al has reported an increasing incidence 
of both juvenile-onset Crohn’s disease and ulcerative 
colitis in Scotland between 1981 and 1995.2  Similarly, 
Hildebrand et al also reported an increase in the 
incidence of Crohn’s disease in northern Stockholm. 
The incidence in their population was higher than that 
reported from other areas. Their results suggested a 
shift in presentation and diagnosis from ulcerative 
colitis towards Crohn’s disease, but also a net increase 
in IBD.  An increase of IBD in children will obviously 
have a knock-on effect in the adult population. 
Pajares et al, having reviewed the epidemiology of 
IBD in Spain describe how IBD has gone from being 
considered a rare disease in Spain to being a relatively 
frequent one.4  Other groups have demonstrated a 
similar trend with regard to the incidence of IBD.5,6  
The rising prevalence is thought to be due to a 
combination of increased incidence and in addition 
increased survival.7 
A second explanation may be an increase in the 
recognition of these disease entities with increased 
awareness and easier availability of diagnostic 
tests. Despite this suggestion, some centres are 
still reporting a high prevalence of undetected 
disease. Howarth et al from Nottingham followed 
patients who were faecal occult blood positive and 
demonstrated that in comparison with detected 
disease, undetected ulcerative colitis is relatively 
common in these patients, but fortunately, usually 
presents with other symptoms to alert the clinician.8 
Other studies have supported the existence of this 
group of patients with undetected IBD, being picked 
up during routine screening examinations or during 
epidemiological studies addressing this exact issue.9, 10
The use of new biological therapies requiring day case 
admission, specifically, anti-TNFα in the management 
of active Crohn’s disease is likely to have made 
a significant impact on the number of day-case 
admissions. It is important to note that patients 
admitted for routine endoscopy on a day-case basis are 
not included in these numbers, and therefore almost 
completely represent patients admitted for anti-TNFα 
infusion. Rubenstein et al, from Chicago followed 
patients with Crohn’s disease who had been treated 
with Infliximab and evaluated their use of hospital 
services. Their study showed a reduction in the number 
of hospitalisations and a decrease in the use of 
surgical service.11  In combination with improvements 
in the medical management of patients with active 
IBD better nutritional management may have had 
an impact on the rate of surgical intervention in the 
management of these patients.
In conclusion, there has been an increase in hospital 
admission for IBD over the last five years in Ireland, 
most dramatically in the day-case admission for 
patients with Crohn’s disease. Average length of stay 
has stayed relatively static and the numbers requiring 
surgery have changed little during this period.
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Table 2
DATA ON SURGICAL INTERVENTION FOR PATIENTS wITH ULCERATIVE COLITIS
INDICATIONS FOR SURGERY SURGICAL PROCEDURES
Failed medical therapy 10 Total colectomy 11
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Perforation 2 Proctectomy and ileostomy 1
Stricture Dilation (in a 
previously formed pouch)
1 Stricture Dilation 1
This table outlines the indications for surgery and the surgical procedures 
performed, on those patients with ulcerative colitis from Beaumont Hospital who 
were included in this audit 
Table 1
DATA ON SURGICAL INTERVENTION FOR PATIENTS wITH CROHN’S DISEASE
INDICATIONS FOR SURGERY SURGICAL PROCEDURES
Stricture 5 Right Hemicolectomy 7
Fistulae 5 Small bowel resection 
Small bowel obstruction 2 Total colectomy 2
Failed medical therapy 2 Anal fistulotomy 2
Abscess 1 Abscess drainage 1
Toxic megacolon 1 Refashioning of Ileostomy 1
This table outlines the indications for surgery and the surgical procedures 
performed, on those patients with Crohn’s disease from Beaumont Hospital 
who were included in this audit.
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InTRODUCTIOn
Cardiovascular mortality rates in Ireland have 
been decreasing steadily in recent years. Although 
Ireland’s rates remain among the highest in Europe, 
the gap between cardiovascular mortality rates for 
Irish men and women under the age of 65 and the 
European Union average is narrowing.1 The Second 
Report on the Implementation of the Cardiovascular 
Health Strategy1 states that in this context the 
number of people living with chronic cardiovascular 
disease is increasing, resulting in an increased 
need for ongoing disease management, secondary 
prevention and cardiac rehabilitation. 
Cardiac rehabilitation has been defined by the 
World Health Organisation2 as the ‘sum of activities 
required to influence favourably the underlying cause 
of the disease, as well as to ensure the patient the 
best possible physical, mental and social conditions 
so that they may through their own efforts preserve, 
or resume when lost, as normal a place as possible in 
the community. Rehabilitation cannot be regarded as 
an isolated form of therapy but must be integrated 
with the whole treatment, of which it only forms 
one facet’. Core components of cardiac rehabilitation 
programmes typically include a combination 
of exercise, psychological and educational 
interventions.,4 Cardiac rehabilitation programmes 
are typically organised in four phases.5 Phase I refers 
to the acute treatment of patients admitted to 
the intensive care unit and the in-hospital stage in 
recovery. Phase II follows discharge from hospital and 
is a period of convalescence for the patient. Phase III 
typically involves a 4-12 week outpatient programme 
incorporating exercise and education classes and is 
usually commenced between the fourth and eight 
Cardiac rehabilitation services in Ireland: 
the impact of a coordinated national 
development strategy
ABsTRACT
Background  The national Cardiovascular Health Strategy including specific plans for cardiac 
rehabilitation was launched in Ireland in 1999. A survey of cardiac rehabilitation 
services was conducted in 200 to evaluate progress on service provision.
Aim To establish levels of service provision, service formats and geographic distribution 
of cardiac rehabilitation services in 200 and compare them with the status pre-
Strategy (1998).
Method  All hospitals in Ireland (n=9) admitting cardiac patients to a coronary or 
intensive care unit were surveyed by postal questionnaire. 
Results  All hospitals provided information and all reported providing Phase I cardiac 
rehabilitation. Seventy-seven per cent (0 of 9) provided Phase III rehabilitation in 
200 (i.e. outpatient cardiac rehabilitation services) compared with 29% (12 of 41) 
in 1998. Of those hospitals currently without programmes, 78% (seven of nine) had 
plans in place for programme establishment. All programmes had trained cardiac 
rehabilitation coordinators, multidisciplinary teams and multiple components 
as recommended in the Strategy. In 82% of hospitals, intervention was provided 
at Phase II (immediate post-discharge period) while 26% of hospitals provided 
intervention at Phase IV (long-term maintenance period).
Conclusions  There have been substantial achievements towards the Cardiovascular 
Health Strategy target of providing cardiac rehabilitation services for all 
relevant hospitals in Ireland over the past five years. Service provision of cardiac 
rehabilitation can benefit from collective efforts made across centres to encourage 
the prioritisation of cardiac rehabilitation in national health policy initiatives.
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week post-discharge, depending upon the amount 
of cardiac damage.6 Phase IV refers to the period 
of long-term maintenance and typically involves 
community-based exercise sessions.
In the past, service provision for cardiac rehabilitation 
in Ireland has been poor. A European Union survey 
of cardiac rehabilitation activity conducted in 1995 
found that Ireland ranked among the lowest in 
relation to the number of cardiac rehabilitation 
programmes per head of population.7 Following 
this, a first national survey of cardiac rehabilitation 
services in 1998 found that only twelve hospitals 
(29% of all hospitals admitting cardiac patients) 
provided outpatient programmes.8 In 1999 the 
national Cardiovascular Health Strategy9 was 
launched which aimed to coordinate and prioritise 
activities in relation to cardiovascular disease 
management. As a result additional resources were 
made available to cardiac rehabilitation services 
and ten recommendations were made specifically 
concerning cardiac rehabilitation. The first of these 
recommendations (R9.1) stated that ‘every hospital 
that treats patients with heart disease should 
provide a cardiac rehabilitation service.’
The aim of the present study was to establish the 
level of service provision of cardiac rehabilitation in 
200. Geographic distribution of current programmes 
is outlined, staff profiles, programme formats and 
patient throughput are described and comparisons are 
made with service provision in 1998. This facilitates the 
assessment of the extent to which recommendation 
R9.1 has been achieved and evaluates the impact of 
the national Cardiovascular Health Strategy on cardiac 
rehabilitation service provision.
METHOD
All general hospitals admitting cardiac patients to 
a coronary or intensive care unit in Ireland (n=9) 
were surveyed by postal questionnaire to cardiac 
rehabilitation coordinators or clinical nurse managers 
of the coronary or intensive care unit as appropriate. 
Information was sought on the cardiac rehabilitation 
phases (phases I-IV) provided by the hospital; 
components of each phase and staffing levels. Where 
Phase III outpatient programmes were provided, 
programme formats (i.e. number of sessions and 
patients per group) and the number of new patients 
attending in the previous year were queried. Where 
outpatient programmes were not provided, information 
was sought on plans to develop programmes. Following 
telephone reminders the final response rate was 100%.
REsULTs
Seventy-one per cent of hospitals admitting cardiac 
patients provided an outpatient (Phase III) cardiac 
rehabilitation programme in 200 compared with 
29% in 1998 (Figure 1). There was 100% provision 
in six of the health board areas. The Mid-Western 
Health Board provided services in 50% of hospitals 
while the Southern Health Board had the least 
developed cardiac rehabilitation services with only 
1% (one of eight ) of hospitals providing cardiac 
rehabilitation services. Of those hospitals currently 
without outpatient services, seven of nine had 
advanced plans to develop programmes and six 
of nine of these hospitals already had a cardiac 
rehabilitation coordinator in place. Hospitals without 
outpatient services cited lack of funding, lack of staff 
and lack of available space as the greatest barriers to 
programme development.
The number of new patients entering phase III 
programmes in 2002 was available from 71% of 
centres who provided programmes in the previous 
year (Table 1). The remaining hospitals were unable 
to provide throughput figures. Programmes in the 
Eastern Regional Health Authority enrolled most 
patients (1164 in total) while the smallest number was 
seen in the Midland Health Board area (50 in total). 
Across all centres providing information in 2002, a 
total of 2448 patients were enrolled compared with 
696 in 1996. This demonstrates a substantial increase 
in patient throughput. Most centres (96%) placed no 
age restrictions on entry to the programme.
Phase III programmes lasted for a median of 8 weeks, 
including a median of 24 exercise sessions and a 
median of eight education sessions (Table 2). 
Typically six to eight patients were seen in exercise 
and education sessions. A wide range of components 
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was offered by phase III programmes and matched 
core components recommended by national and 
international guidelines.,4,5 Almost all centres 
(ranging from 96-100%) provided education 
on cardiac disease, exercise, smoking cessation, 
medications, nutrition and stress management. 
Eighty per cent provided psychological advice; 77% 
provided sexual counselling and 5% provided 
support for vocational rehabilitation. Table  
shows the mean amount of time spent on each 
component across centres. Most time was spent on 
cardiac education, relaxation training and nutrition 
education.
The multidisciplinary team comprised a variety 
of health professionals. There is evidence of a 
substantial increase in professional input to 
programmes since 1998 (Table ). All centres had a 
designated cardiac rehabilitation coordinator who 
held at minimum a diploma level qualification 
or higher in cardiac rehabilitation training. 
Staff members who provided most time to 
the programme were cardiac rehabilitation 
coordinators, cardiac rehabilitation nurses, dieticians, 
physiotherapists and secretarial staff. Time 
designated to the programme by all professional 
categories has increased from a mean of 45.9 hours 
per week in 1998 to a mean of 11.1 hours per week in 
200. Despite these increases, centres have reported 
several concerns with staffing levels. Thirty per cent 
of centres reported needing increased time from 
a psychologist; 0% needed increased dietician 
time; 2% reported concerns about lack of cover for 
annual leave and 6% reported the need to appoint a 
vocational counsellor.
Service provision levels of phases I, II and IV provided 
by each hospital were also established. Phase I 
cardiac rehabilitation was provided in 100% of 
hospitals. Clinical management issues (e.g. education 
on diagnosis, diagnostic testing, blood pressure, 
medications and family history) and risk factor 
management issues (e.g. education on smoking, 
weight reduction advice, lipid lowering advice and 
risk factor assessment) were addressed by almost 
all centres. Psychosocial management issues 
were addressed by a majority of hospitals: 85% 
provided psychological advice; 82% provided sexual 
counselling and 67% provided vocational counselling. 
Post-hospital management issues proved to be the 
weakest components of phase I intervention. While 
100% of hospitals provided discharge advice, three-
quarters (74%) issued an individual patient plan 
for self-care and lifestyle change and 52% provided 
home needs assessment. The Heart Manual [10] 
(a six-week home-based post MI rehabilitation 
programme) was issued in phase I in 6% of 
hospitals.
Phase II cardiac rehabilitation was provided in 82% 
of hospitals. Risk factor education was the main 
intervention with 72% of all hospitals providing 
smoking cessation education and 66% providing 
nutrition education in Phase II. Psychosocial 
management was again less widely addressed: 49% 
provided psychological advice, 46% provided sexual 
counselling and % provided vocational counselling. 
In a majority of hospitals, care was delivered by 
telephone (64%) while individual outpatient (41%) 
and group outpatient (%) appointments were 
offered in a number of centres. The Heart Manual 
was issued in phase II in 2% of centres. Home visits 
was the least frequent method of care delivery (1%).
Twenty-six per cent of hospitals reported that 
they provided a formal phase IV programme while 
outpatient appointments post-phase III were 
offered in % of hospitals. Some hospitals referred 
patients to support groups (26%) and community 
exercise classes (21%). About half of hospitals had 
links with general practitioners (56%); % linked 
with health promotion teams and 18% had links 
with community leisure centres.
DIsCUssIOn
The second national survey of cardiac rehabilitation 
service provision in Ireland has shown that over three 
quarters of hospitals admitting cardiac patients 
now provide an outpatient cardiac rehabilitation 
programme. This is a marked increase since 1998 
when only 29% of hospitals provided programmes. 
It demonstrates that substantial progress has 
been made in achieving Recommendation R9.1. 
of the national Cardiovascular Health Strategy. 
It is envisaged that 100% service provision will 
be reached in the near future since seven of nine 
hospitals without outpatient programmes have 
plans to develop them. However, hospitals have 
reported several obstacles in achieving their plans 
such as lack of funding, staffing and available space.
The increases in programme numbers has been 
paralled by increases in patient throughput. There 
have also been marked increases in the time 
dedicated to programmes by health professionals 
since 1998. All categories of health professionals 
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Table 1
NEw PATIENTS ENTERING PHASE III CARDIAC REHABILITATION PROGS. BY HEALTH BOARD AREA IN 2002 AND 1996
HEALTH BOARD 
AREA
INFORMATION 
AVAILABLE IN 2002* 
NEW PATIENTS 
IN 2002
INFORMATION 
AVAILABLE IN 1996**
NEW PATIENTS 
IN 1996
ERHA 6 (8) 1164 4 (6) 526
NEHB  (4) 197 1 (1) 75
NWHB 2 (2) 192 1 (1) 22
WHB  (4) 29 0 (1) -
MWHB 2 (2) 15 - -
MHB 1 () 50 0 (1) -
SEHB  (4) 417 1 (2) 7
SHB 0 (1) - -
TOTAL: 20 (28) 2448 7 (12) 696
*(Total number of hospitals with programmes in 2002)
**(Total number of hospitals with programmes who replied in 1996)
Table 2
STRUCTURE, FORMAT & DURATION OF PHASE III CARDIAC REHABILITATION PROGRAMMES PROVIDED (N=30)
MEAN (SD) MEDIAN RANGE
Duration of programme (weeks) 8.6 (2.) 8  (6-18)
Number of exercise sessions 19.7 (8.0) 24 (2-0)
Number of education sessions 9.4 (4.1) 8 (2-24)
Number of participants per exercise group 6.2 (1.4) 6  (4-10)
Table 3
EDUCATION COMPONENTS OF PHASE III CARDIAC REHABILITATION PROGRAMMES
COMPONENT
DURATION OF COMPONENT (MINS) 
MEAN (SD)
MEDIAN RANGE
Cardiac education 71. (45.9) 60 (0-260)
Relaxation training 71. (58.4) 60 (15-280)
Nutrition 67.8 (1.9) 60 (0-150)
Exercise education 60.2 (6.0) 60 (0-180)
General psychological advice 45.4 (4.1)) 45 (0-200)
Smoking cessation 5.2 (2.8)) 0 (0-90)
Medication 26. (4.6) 45 (0-120)
Sexual counselling 25.4 (24.5) 17.5 (0-90)
Vocational counselling 18.0 (24.5)) 0 (0-90)
Diabetic advice* 9.5 (16.5) 0 (0-60)
* Where required
Table 4
NUMBER OF HOURS PER wEEK PROVIDED TO PHASE III PROGRAMMES BY PROFESSIONAL CATEGORY 
PROFESSIONAL
HOURS PER WEEK IN 1998 
MEAN (SD)
HOURS PER WEEK IN 2003 
MEAN (SD)
CR Co-ordinator 28.2 (14.1) 7.2 (25.7)
CR Nurse 7.5 (12.7) 19.8 (24.6)
Dietician .1 (8.1) 1.0 (14.8)
Physiotherapist 2.8 (5.1) 17.7 (16.8)
Psychologist 1.7 (4.4) 2.9 (6.6)
Occupational therapist 0.7 (2.) 2.8 (7.7)
Pharmacist 0.5 (0.5) 2. (5.5)
Social worker 1. (4.7) 2.6 (7.6)
Vocational counsellor <1 centre 0.8 (.6)
Secretary 0.1 (0.2) 10. (12.5)
Smoking cessation officer - 1.7 (7.)
Cardiac liaison nurse - 1.1 (6.7)
Diabetic nurse - 0.1 (0.4)
Health promotion tutor - 0.7 (0.4)
TOTAL: 45.9 (-) 11.1 (67.8)
are now giving more time to cardiac rehabilitation 
programmes. Furthermore, additional types of health 
professionals are involved in the multidisciplinary 
team, such as smoking cessation officers, cardiac 
liaison nurses, diabetic nurses and health promotion 
tutors. Despite these additions, concerns over 
staffing levels remain and in particular centres 
have highlighted need for increased hours from 
psychologists and dieticians.
In phase III, all centres addressed a majority of 
core components as recommended by national 
and international guidelines. A minority of centres 
did not offer psychological advice or education on 
sexual and vocational rehabilitation in phase III 
and these issues were also less well addressed in 
phase I and phase II. The diagnosis of coronary heart 
disease has major psychological consequences 11 
and evidence shows that patients can benefit from 
psychological intervention. A recent meta-analysis 
of psychoeducational programmes for coronary 
heart disease patients found a 4% reduction in 
cardiovascular mortality and 29% reduction in the 
recurrence of myocardial infarction.12 Post-discharge 
issues were also less widely addressed both after the 
phase I period (where issues such as home needs 
assessment and use of the Heart Manual were not 
widely addressed) and after the phase III programme 
(where only 26% of centres provided Phase IV 
intervention). As the aim of cardiac rehabilitation is to 
facilitate long-term life-style changes,1 interventions 
dealing with the issues of long-term maintenance 
would be desirable. Notwithstanding this, the 
fact that all hospitals provided Phase I cardiac 
rehabilitation and 82% provided Phase II means that 
those patients not attending a phase III outpatient 
programme can benefit from cardiac rehabilitation 
intervention during these earlier stages.
The rapid expansion in cardiac rehabilitation services 
is evident following a focused health service strategy 
in which cardiac rehabilitation was prioritised. 
This suggests that service provision of cardiac 
rehabilitation can benefit from collective efforts 
made across centres to encourage the prioritisation 
of cardiac rehabilitation in national health policy 
initiatives. The next challenge is to ensure optimum 
levels of service uptake among cardiac patients. A 
recent study estimating the total number of patients 
referred to and completing cardiac rehabilitation 
programmes in the UK in 200014 found that only 
45-67% of patients were referred while just 27-41% 
attended. The adoption of a standardised audit 
system would allow centres to track patient uptake 
CARDIAC REHABILITATION SERVICES IN IRELAND: THE IMPACT OF A COORDINATED NATIONAL DEVELOPMENT STRATEGYD lavin et al
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of services and assess patient outcomes. Inability 
to provide figures by almost one in three centres on 
patient throughput suggests that administrative 
aspects of the cardiac rehabilitation services are 
currently underdeveloped. This underscores the 
importance of introducing a standardised audit 
system to facilitate routine data collection. The 
development of a standardised cardiac rehabilitation 
audit tool in Ireland is now at an advanced stage. 
This will facilitate an evidence-based continuous 
improvement approach to the provision of cardiac 
rehabilitation services in Ireland.
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InTRODUCTIOn
The first case of laparoscopic adrenalectomy was 
reported in 19921 since when laparoscopy has 
become the approach of choice for adrenalectomy, 
especially in cases of benign tumours and isolated 
metastasis from lung cancer. As with laparoscopic 
cholecystectomy there are a number of arguments 
in favour of this technique; incisions are small, most 
referred disease is benign and there is excellent 
visualisation because of the magnification of an 
anatomically demanding area. Reported advantages 
over conventional adrenalectomy include decreased 
blood loss, lower requirement for post-operative 
analgesia, shorter hospital stay and reduced costs.2-8 
This study reports our initial experience of this 
procedure.
PATIEnTs AnD METHODs
Study Group
Details of patients undergoing laparoscopic 
adrenalectomy were prospectively documented 
between October 2001 and June 200 at Beaumont 
Hospital, Dublin. The indications for surgery were 
benign inactive adrenal tumours of 6cm or less in 
size or hormonally active tumours of the adrenal. 
Hormonally inactive tumours larger than 6cm have 
a higher risk of malignancy9 and therefore were also 
excluded. Although large glands do pose particular 
problems in relation to safety of dissection, and are 
considered by many authors to be a contraindication, 
a number of reports exist of lesions up to 1cm 
successfully treated with laparoscopy.,8 Glands 
which demonstrated any radiological features 
suggestive of malignancy (local invasion, irregular 
borders, obliteration of fat planes, lymphadenopathy 
or other intra-abdominal metastasis) were similarly 
excluded. All patients with hormonally active glands 
were investigated by the endocrinology service, 
and similarly all ‘incidentalomas’ were seen in 
consultation with the endocrinology service and 
proven to be biochemically inactive.
The three patients with phaeochromocytomas were 
commenced on α-blockade with phenoxybenzamine 
until orthostatic hypotension was apparent and then 
beta-blocked with atenolol. Patient demographics, 
pathology and operative characteristics were 
recorded. All patients were reviewed at a clinic six 
weeks following surgery. 
Operative technique
Patients were placed in the lateral decubitus position, 
with the affected side elevated and extended. 
Pneumoperitoneum was then achieved at 15mmHg 
through a Verres entry 2cm below the costal margin 
of the affected side, medial to the anterior axillary 
line. A 10mm trocar was inserted though this incision 
to accommodate a 25° angled laparoscope. One 
Laparoscopic adrenalectomy, an initial 
experience of fifteen cases
ABsTRACT
Background  Laparoscopic adrenalectomy is an attractive alternative to open surgery, but 
making the transition can be difficult.  
Aim To evaluate the initial experience of a general surgical team at a single institution at 
making the transition.  
Methods The details of 15 patients undergoing laparoscopic adrenalectomy were 
prospectively recorded over a 21-month period.  
Results Fifteen glands were removed from fifteen patients.  Nine of these were 
left-sided.  The mean gland size was .4 cm.  Pathology included six non-
functioning adenomas, four Conn’s syndrome, two Cushing’s syndrome and 
three phaeochromocytomas.  Mean operating time was 74 minutes (range 1-172 
minutes), with one conversion to open procedure. There were no morbidities and no 
mortality.  
Conclusion Our initial experience demonstrates this approach to be the ideal technique 
for removal of benign adrenal tumours with significant advantages for the patient.
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further 10mm port and one further 5mm port were 
then inserted along the costal margin caudad to the 
camera. A Harmonic Scalpel (Ultracision; Ethicon 
Endo-Surgery) was used to dissect the area around 
the adrenal gland and was excellent for maintaining 
a dry field and for facilitating identification of the 
adrenal vein. The adrenal gland was removed with 
the surrounding fat intact using an extraction bag. 
In all but two cases the initial incision had to be 
enlarged to facilitate extraction.
For left-sided lesions the following approach was 
used;
i) mobilisation of splenic flexure followed by medial 
mobilisation of spleen by division of lienorenal 
and diaphragmatic ligamentous attachments,
ii) identification of the splenorenal groove which 
guides the operator to the renal vein,
iii) dissection and ligation with titanium clips of the 
left adrenal vein,
iv) completion of adrenal dissection staying outside 
the peri-adrenal fat to minimise bleeding or 
breach of the gland.
For right-sided lesions the technique involved;
i) division of the lateral ligaments of the liver to 
partially mobilise the right lobe of liver,
ii) identification of the right renal vein and inferior 
vena cava prior to clipping and division of the 
right adrenal vein,
iii) completion of mobilisation of the adrenal gland.
REsULTs
Fifteen patients with a mean age of 54 years (range 
8-70 years) underwent laparoscopic transperitoneal 
adrenalectomy (Table 1). Of the fifteen, nine patients 
were female and six were male with a mean age 
of 49 years and 54 years respectively. The average 
tumour size was .4cm (range 0.8-8cm). 
The mean operative time (incision to closure) was 
74 minutes, with a range of 1 – 172 minutes. Post-
operative discharge time had a mean of .1 days 
(range 2-7 days). One male patient with bilateral 
adrenal hyperplasia, who had previous upper 
abdominal surgery for trauma, was converted to an 
open procedure due to inability to identify the gland. 
There was no morbidity and no mortality. 
DIsCUssIOn
The results of 15 initial cases of laparoscopic 
adrenalectomy at our institution are presented. 
There is a learning curve for this procedure and with 
Table 1
DEMOGRAPHIC, TUMOUR AND OPERATIVE 
CHARACTERISTICS
Patients 15
Sex, Male/Female 6/9
Side, left/right 9/6
Adrenal Disease:
Adenoma
Conn’s Syndrome
Cushing’s Syndrome
Phaeochromocytoma
6
4
2

Mean Age, years (range) 54 (8-70)
Mean Size, cm (range) .4 (0.8-8)
Operative Time, minutes (range) 74 (1-172)
Conversion to open procedures 1
Length of stay, days (range) .1 (2-7)
Figure 1 —
CT IMAGE OF SMALL 
LEFT-SIDED ADRENAL 
ADENOMA
experience comes a reduction in surgical time,10-12 
peri-operative morbidity1 and cost.7 Meria et al 
(200) found that most reported complications came 
at the beginning of the learning curve.14 The only 
absolute contraindication to laparoscopic resection 
of adrenal tumours is invasive carcinoma requiring 
extensive excision, but the presence of a large 
right lobe of liver or previous abdominal surgery 
are only relative contraindications to surgery.15 The 
latter accounted for the only conversion to open 
laparotomy in this series, and accounted for the 
longest operative time of 172 minutes.
Our experience leads us to conclude that left-sided 
lesions were less technically challenging than right-
sided lesions. Although operative times were shorter 
for right-sided lesions (mean 59 vs 81 minutes), 
if we exclude the left-sided case which required 
conversion, the times are similar (mean 59 vs 6 
minutes). In addition smaller lesions (Figure 1) were 
found to be subjectively less technically challenging 
than larger lesions.
Ultrasonic dissection presents a significant 
advantage by offering excellent haemostasis and 
better visualisation of tissue planes. This has been 
shown to reduce operative time and cost relative to 
conventional devices for this procedure.16
Laparoscopic resection of phaeochromocytomas is 
challenging due to their highly vascular nature, their 
tendency to be larger than non-secreting lesions 
and their potential for blood pressure surges due to 
intra-operative catecholamine release. Three patients 
with phaeochromocytomas were included in this 
study. These patients had effective α and α adrenergic 
blockade pre-operatively. There were no significant 
intra-operative or post-operative complications with 
respect to blood pressure or heart rate, although 
one patient required a nitroprusside infusion intra-
operatively. During the mean follow-up of eight 
months there were no recurrences, the patients 
remain normotensive and long-term follow-up 
continues. Our early experience would support the 
growing evidence that phaeochromocytoma is not a 
contraindication to endoscopic resection.17-19
COnCLUsIOn
Our initial experience with laparoscopic 
adrenalectomy was encouraging. The procedure 
has an appreciable learning curve and therefore 
should only be performed against a background of 
significant laparoscopic experience. We believe it to 
be the operation of choice for benign or hormonally 
active adrenal disease.
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InTRODUCTIOn
Fractures of the femoral neck occur in two different 
patient populations. A very small group (-5%) are 
young patients subjected to higher energy trauma, 
usually motor vehicle crashes and falls from a height. 
The remainder occur in the elderly population 
and approximately 90% of these injuries are the 
result of a simple fall from the standing position.1 
The aims of our study were to evaluate the clinical 
and radiological outcomes of internal fixation of 
intracapsular fractures of femoral neck in patients 
between the ages of 20 and 60 years, and to 
determine the reasons for failure.
PATIEnTs AnD METHODs
Thirty-nine patients between the ages of 20 and 60 
years were treated for intracapsular fractures of the 
femoral neck between 1995 and 2000. This represents 
5.6% of the total femoral neck fractures admitted to 
the unit during this period including all age groups. 
Three patients were excluded from our study: one 
patient had osteogenesis imperfecta, another 
patient was mentally retarded and wheel chair 
bound pre-operatively, and the third patient had a 
fracture dislocation with an associated fracture of the 
acetabulum. Thirty-six patients eligible for the study 
were invited to attend a review clinic. Twenty nine 
patients attended the clinic. Of the seven patients who 
did not attend, four were contacted on the phone and 
their medical records were studied. No contact was 
possible with three patients.
The patients were assessed clinically and 
radiologically. Functional assessment was performed 
using the Harris hip score.2 Pre-operative and post-
operative radiographs were studied to determine the 
fracture type and reduction achieved. Radiographs 
were also assessed for non-union, evidence of 
avascular necrosis and loss of reduction. The Garden 
Index was used to evaluate reduction of fracture. 
On the AP view the angle formed by the medial 
cortex of femoral shaft and the primary compressive 
trabeculae in the head and neck normally measures 
160 degrees. An angle of less than 155 degrees was 
taken as an unacceptable varus reduction and one 
more than 180 degrees was considered as severe 
valgus reduction. Radiological evidence of avascular 
necrosis, non-union or conversion to arthroplasty 
was regarded as failure.
REsULTs
Of the  patients reviewed, 16 were male and 17 
were female whose mean age was 46. years at the 
time of surgery. Mean follow-up was 7.7 months 
(range 18-76 months). The mechanism of injury was 
higher energy trauma in 26 patients (78.8%). Ten 
patients (0%) had an undisplaced fracture (Garden 
type 1 or 2), while 2 patients (70%) had a displaced 
Intracapsular fractures of the femoral neck 
in younger patients
ABsTRACT
Background  Most femoral neck fractures in younger patients have a different 
mechanism, treatment, and prognosis from those in elderly patients.
Aims To evaluate the results of internal fixation of femoral neck fractures in patients 
aged between 20 and 60 years, and to determine reasons for failure.
Patients and Methods Thirty three patients aged between 20 and 60 years who sustained 
a femoral neck fracture between 1995 and 2000 were reviewed. This represents 
5.6% of the total femoral neck fractures admitted to the unit during this period.
Results  In 26 patients (78.8%) the fracture resulted from higher energy trauma. Of 2 
patients with displaced fractures four patients (17.4%) developed avascular necrosis 
and one patient (4.%) developed non-union. Factors influencing outcome were 
mechanism of injury, pre-operative fracture displacement, adequacy of fracture 
reduction and delay in surgery.
Conclusion Our study emphasises the importance of timely surgery and adequate 
reduction of displaced femoral neck fractures in younger patients.
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SH Orkazai, 
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fracture (Garden type  or 4). All patients with 
undisplaced fractures healed without any evidence 
of avascular necrosis or non-union, so further 
analysis is confined to the review of the patients 
with displaced fractures only. 
Of the 2 patients with displaced fractures, 15 (65.2%) 
underwent screw fixation and eight patients (4.8%) 
were treated with sliding hip screw plate fixation with 
or without a Derotation screw. Three patients under 
went surgery within 12 hours of injury, 18 patients 
underwent surgery between 12 to 24 hours of injury 
and in two patients surgery was delayed for more 
than 24 hours. Intra-operative fracture reduction was 
anatomical in 14 patients and five fractures were fixed 
in acceptable valgus impaction. Fracture reduction 
was inadequate in four patients with three having 
residual displacement and one fracture was fixed in 
varus. Open reduction was performed in one patient 
due to failed closed reduction. 
Seventeen of 2 patients (7.9%) healed without 
any radiological evidence of avascular necrosis, 
non-union or osteoarthritis. Four patients (17.4%) 
developed avascular necrosis while one patient (4.%) 
developed non-union and underwent conversion to 
hemiarthroplasty (Table 1). One patient (4.%) showed 
early osteoarthritic changes 68 months after surgery 
with mild symptoms. Impaction at the fracture site 
resulted in screws protruding laterally in two patients. 
These patients underwent removal of screws after the 
fracture union. 
Five patients who developed avascular necrosis and 
non-union had displaced fractures. In three of these 
five patients, fractures resulted from high velocity 
injuries. Two had associated life threatening injuries 
which delayed their fracture fixation for three and 
seven days respectively. Four fractures were fixed 
with parallel screws and one fracture was fixed 
using dynamic hip screw plate. Four patients had 
inadequate reduction of their fractures, there was 
residual displacement in three fractures after fixation 
and one fracture was fixed in varus (Figure 1). One 
fracture pattern was of vertical shear type (Figure 2). 
DIsCUssIOn 
Protzman and Burkhalter4 emphasised three basic 
differences between femoral fractures in younger 
patients and those in elderly patients. Firstly, they 
are uncommon. Secondly, the reported results of 
treatment are notably poorer compared to those in 
older patients. Also, there is a significant difference in 
the severity of trauma required to cause this fracture 
in young adults. Higher kinetic energy is necessary to 
produce a non-pathological femoral neck fracture in 
younger patients. These patients can have associated 
life threatening injuries. They related the non-
union and avascular necrosis rates directly to the 
high energy trauma responsible for the fractures. 
In our series, three of four patients who developed 
avascular necrosis sustained their fracture following 
high energy trauma.
Avascular necrosis remains the main complication 
following internal fixation of intracapsular femoral 
fractures. Revascularisation of the femoral head after a 
fracture is a slow process. Calandruccio and Anderson5 
obtained autoradiographs of 11 femoral head 
specimens removed from the patients who had been 
given radioactive phosphorus before hemiarthroplasty 
for an acute intracapsular fracture. They reported 
that approximately 22% of the femoral heads were 
completely vascular, 47% were partially vascular, and 
2% were completely avascular. Sevitt6 performed 
arteriographic and histological studies on 25 femoral 
Table 1 
Results
METHOD 
OF 
FIXATION
TIMING OF 
SURGERY 
(HOURS)
NO. OF 
PATIENTS
SATISFACTORY 
REDUCTION 
(ANATOMICAL + VALGUS)
UNSATISFACTORY 
REDUCTION (RESIDUAL 
DISPLACEMENT + VARUS)
UNEVENTFUL 
HEALING (HARRIS 
HIP SCORE >80)
AVN
NON-
UNION
EARLY 
OA
DHS <12 1 1 - 1 - - -
12-24 7 6 1 6 - 1 -
>24 - - - - - - -
Screw 
fixation
<12 2 2 - 2 - - -
12-24 11 8  8 2 - 1
>24 2 1 1 - 2 - -
Ma Farooq et alINTRACAPSULAR FRACTURES OF THE FEMORAL NECK IN YOUNGER PATIENTS
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heads obtained at autopsy of patients who had 
sustained an intracapsular fracture and they found 
total or partial necrosis in twenty one specimens. 
There are three criteria for the successful treatment 
of femoral neck fracture in young patients: 
(i) fixation must be achieved within twelve hours of 
injury; (ii) anatomical reduction must be obtained 
through an open reduction if necessary; and 
(iii) the fracture must be stabilised with some 
form of multiple screw fixation. It is believed that 
circulation may improve after anatomical reduction 
and fixation through a reduction of the deforming 
forces on the remaining blood vessels.7 Tooke and 
Favero8 described 2 patients less than 50 years of 
age who had femoral neck fractures. Multiple devices 
were used for fixation and a capsulotomy was 
performed in only one hip. All patients with Garden 
1 & 2 fractures healed without avascular necrosis. 
Patients with Garden  & 4 fractures had a 5.5% rate 
of non-union and a % rate of avascular necrosis. 
They reported only a single case of non-union, which 
they believed was due to failure to achieve adequate 
reduction. They emphasised the importance of 
achieving an anatomical reduction and performing 
reduction and internal fixation as soon as possible 
after injury. In our series, inadequate reduction was 
the significant factor among four of five patients 
who developed complications of AVN or non-union. 
One patient in our series who developed AVN had 
a fracture with vertical shear pattern. Pauwels9 
attributed non-unions in type  fractures to the 
increased shearing force of this vertical fracture.
Swiontkowski et al10 presented 27 patients between 
the ages of 12 and 49 years who suffered femoral 
neck fractures. The fractures were treated with 
anatomical reduction, capsulotomy and fixation 
with 6.5mm A-O screws in a box pattern. The surgical 
procedures were done within eight hours of injury. 
All fractures in their series united. Avascular necrosis 
developed in 22% of the patients. They attributed the 
absence of non-union and low incidence of avascular 
necrosis to immediate reduction and internal 
fixation with compression. In our series, delay in 
surgery was a significant factor in two patients who 
developed avascular necrosis. On the other hand, 
Upadhyay et al11 in a prospective randomised study 
found that a delay of more than 48 hours before 
surgery did not influence the rate of union or the 
development of non-union when compared with 
operation within 48 hours of injury.
Figure-1 (a) —
POST-OPERATIVE 
RADIOGRAPH OF A 
53-YEAR-OLD MALE 
SHOwING FRACTURE 
FIXED IN VARUS
Figure-1 (b) —
INADEQUATE 
REDUCTION LEADING 
TO NON-UNION
Figure-2 (a) —
INTRA-OPERATIVE 
RADIOGRAPH OF 
A 53-YEAR-OLD 
FEMALE SHOwING 
INADEQUATE 
REDUCTION OF A 
VERTICAL SHEAR TYPE 
FRACTURE
Figure-2 (b) —
RADIOGRAPHS TAKEN 
14 MONTHS AFTER 
SURGERY SHOwING 
SIGNS OF AVASCULAR 
NECROSIS AND 
PROTRUDED SCREwS
Figure-2 (c) —
RADIOGRAPH TAKEN 
19 MONTHS AFTER 
SURGERY SHOwING 
AVASCULAR 
NECROSIS
Anatomical reduction is optimal and should be 
achieved by open reduction if necessary. Cave12 
emphasised anatomical reduction in younger 
patients and recommended if one attempt at closed 
reduction fails, the surgeon should proceed directly 
to open reduction through an anterior approach. 
Valgus impaction provides a stable mechanical 
configuration.1 Varus reduction is not acceptable. 
In our series all fractures fixed in valgus impaction 
united without any complication while one fracture 
that was fixed in varus developed non-union.
2(a)
1(a) 1(b)
2(c)2(b)
If multiple screw fixation is used as a method of 
fixation, the triangular and diamond patterns of 
fixation adapt well to the different forces applied 
to the hip in different body positions.14 Bout et 
al15 described the “three point principle” for the 
fixation of fractures. Both ends of the screws are 
anchored in the firm bone of lateral femoral cortex 
and subchondral bone of the head. The shafts of 
the screws are positioned to rest against the inner 
surface of the cervical cortex along the inferior and 
posterior borders. Subchondral screw fixation is 
recommended for better purchase.16 Parker et al17 
compared parallel and crossed Garden screws and 
found that parallel screws were associated with 
lower incidence of non-union and avascular necrosis. 
In another study, Parker18 described patient’s age 
and pre-operative fracture displacement to be of the 
greatest value in predicting non-union. Although 
overall complication rate was higher among the 
patients in our series who underwent screw fixation 
as compared to those who underwent sliding screw 
fixation (0.8% as compared to 12.5%), there were 
other associated factors for failure, hence these 
results are difficult to compare.
 
COnCLUsIOn
Avascular necrosis and non-union are the most 
serious complications following displaced femoral 
neck fractures. High energy trauma, pre-operative 
fracture displacement, delay in surgery and failure 
to achieve adequate reduction are the factors 
contributing to these complications. Our study 
emphasises the importance of timely surgical 
intervention (preferably within 12 hours of injury) 
and adequate reduction while dealing with displaced 
femoral neck fractures in younger patients. Although 
these recommendations are extensively documented 
in the literature, they are sometimes overlooked 
resulting in serious complications.
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InTRODUCTIOn
Dementia is one of the most common and costly 
forms of cognitive impairment in the elderly. 
Dementia is a gradual, progressive decline in mental 
ability that affects memory, thinking processes, 
behaviour and physical activity. It is acquired and 
persistent and results in impaired activities of 
daily living. Different forms of dementia have been 
defined, but Alzheimer’s disease (AD) is the leading 
form, which accounts for 65% of all dementias,1 while 
vascular dementia is the second most frequent form 
of dementia.2 Of concern, the incidence of AD is 
expected to grow exponentially in the next 50 years. 
AD is a complex multifactor disease which involves 
environmental and genetic factors, particularly 
possession of an ε-4 allele of the apolipoprotein E 
(APOE) gene.2 Other firmly established risk factors 
are increasing age, a family history, which raises the 
risk 2- to 5-fold,4 and Down’s syndrome.5 The risk of 
AD increases further as more of these factors are 
combined.
While a curative treatment of cognitive impairment 
is currently impossible, current drug therapies, 
if started early enough, may slow down the 
progression of the condition. Therefore, it is 
important to plan prevention strategies and to 
diagnose early. The Mini Mental State Examination 
(MMSE) is a brief and widely used method for 
assessing cognitive mental status.6 Several studies 
have examined the association of performance on 
the MMSE with APOE genotype, but the findings 
have been mixed.7,8 
Screening for sensorial impairment is a secondary 
objective in the context of neurodegenerative 
diseases. Olfactory deficit, involving identification, 
recognition and detection of odours, is a sign of some 
neurodegenerative diseases.9 Impaired olfactory 
detection predicts cognitive decline in non-demented 
older adults10 and has also been observed in first-
degree relatives of patients with AD.11,12 Few studies 
have examined the association of performance 
in olfactory tests with APOE genotype, with some 
studies finding no effect of APOE genotype 10,11, while 
Wang et al1 reported that in patients with mild 
cognitive impairment, those with ε-4 allele detected 
less odours than those without the ε-4 allele. 
Moreover, Murphy14 reported significant deficits in 
odour identification in persons carrying an ε-4 allele, 
but who did not yet show evidence of dementia.14 
Therefore, the aim of the present study was to 
Olfactory function in people with genetic 
risk of dementia
ABsTRACT
Background  Screening for sensorial impairment is a secondary objective in the context 
of neurodegenerative diseases, including dementias. For example, olfactory 
dysfunction is among the first signs of Alzheimer’s disease. There has been no 
study of olfactory function in Irish subjects at risk of dementia. 
Aim To investigate olfactory function in non-demented Irish persons, who carry genetic 
risk factors for dementia. 
Methods  Thirty-eight Irish adult subjects, who are at risk of dementia, were recruited. 
Cognitive performance and olfactory function were assessed and apolipoprotein E 
(APOE) genotype determined. 
Results  Three and six subjects had a Mini Mental State Examination (MMSE) and Brief 
Smell Identification Test (B-SIT) score, respectively, outside the normal range. While 
five out of the fifteen ε-4 allele positive subjects had B-SIT scores outside the normal 
range, only one out of the twenty-three ε-4 allele negative subjects had; the difference 
in this frequency was significant (P=0.025). There was no significant difference 
(P=0.266) in the frequency of abnormal MMSE scores between ε-4 allele groups. 
Conclusion  Further investigation is required to explore the reasons for the higher 
prevalence of olfactory dysfunction in ε-4 allele positive subjects.
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investigate olfactory function in non-demented Irish 
persons, who carry genetic risk factors for dementia. 
sUBJECTs AnD METHOD
Subjects
Thirty-eight subjects (26 women and 12 men; mean 
[SD] age, 58.0 [9.4] years) were recruited through an 
advertisement circulated among the members of 
the Alzheimer’s Society of Ireland (n = 26) and at the 
Cork University Hospital (n = 12). Inclusion of first 
degree blood relatives of people with AD increased 
the frequency of ε-4 allele-positive subjects. The 
following exclusion criteria were applied: smokers 
(ex or current), local respiratory tract factors such 
as active rhinitis or sinusitis (allergic or infectious), 
history of septum surgery, depression, and stroke. 
26.%, 4.2% and 9.5% of subjects had attained 
primary, secondary and tertiary educational status, 
respectively.
Ethical Considerations
Before participation in this study, all subjects signed 
an informed consent document approved by the 
Clinical Research Ethics Committee of the Cork 
Teaching Hospitals. 
Study design
This was an association study which examined 
the relationship between APOE genotype and 
cognitive performance and olfactory function in 
a cohort of Irish adults at risk of dementia. After 
recruitment, each participant was assessed for 
cognitive mental status and olfactory function. In 
addition a cheek swab was taken for DNA analysis. 
Cheek swabs containing buccal cells were used 
for DNA isolation by a PURGENE® genomic DNA 
purification kit (Promega Corporation, Madison, 
WI, USA). This isolation technique resulted in high 
molecular weight DNA (>20 kb) that was free of RNA 
contamination and had a 260/280 absorbance ratio 
>1.7. The isolated DNA was then stored at -20°C until 
required for analysis.
Assessment of cognitive performance and olfactory 
function were made prior to and independently of, 
the APOE genotype, and results were stored in a 
coded fashion.
DNA analysis
Restriction fragment length polymorphisms in the 
APOE gene were determined by polymerase chain 
reaction (PCR) followed by digestion of the amplified 
PCR product with Hha I restriction endonucleases 
as described previously.15 Following restriction 
endonuclease digestion, APOE genotype was 
determined by ethidium-bromide-UVB illumination 
of the fragments separated on non-denaturing 
polyacrylamide gels (150 g/l). Additional Hha I 
restriction sites located throughout the amplified 
sequence do not interfere with the polymorphism 
detection as the five diagnostically important 
fragments of 91 base pairs (bp) (indicates presence 
of ε-2 or ε- allele), 8 bp (indicates presence of ε-2 
allele), α72 bp (indicates presence of ε-4 allele), 48 bp 
(indicates presence of ε- or ε-4 allele) and 5 bp 
(indicates presence of ε- or ε-4 allele) were unique 
and easily identifiable. 
Cognitive performance
As the present study was concerned with the 
overt signs of dementia, the standard version of 
MMSE,6 which offers two alternative forms of 
measuring attention (serial subtraction; S7, and 
backward spelling; WB) was used. A cut-off score 
of 24 out of 0 distinguishes mild dementia from 
normal cognition, depending on age, and education, 
amongst other factors.16
Olfactory function
The shortened version of the University of 
Pennsylvania Smell Identification Test, namely the 
B-SIT,17 was used in the present study. The B-SIT is a 
12-item standardized, four-alternative, forced-choice 
odour-identification task, which takes less than five 
minutes. The stimuli are embedded in ‘scratch and 
sniff’ microcapsules fixed and positioned on strips 
at the bottom of each page. This B-SIT provides an 
accurate screen for olfactory dysfunction (test-retest 
reliability > 0.70).17 
Statistical Analysis
Unpaired t-tests were used to compare mean age, 
MMSE scores and B-SIT scores among ε-4 allele 
positive and ε-4 allele negative subjects. The Fisher’s 
exact test and χ2 test was used to compare male 
to female ratio and percentage of subject attaining 
different levels of educational status, respectively, 
among ε-4 allele positive and ε-4 allele negative 
subjects. The Fisher’s exact tests were used to 
compare the frequency of ε-4 allele positive and ε-4 
allele negative subjects who had MMSE and B-SIT 
scores outside the normal range. In addition, logistic 
regression was used to assess the relationships 
between MMSE and ε-4 allele status as well as 
between BSIT and ε-4 allele status, after accounting 
for confounders (such as age and educational status). 
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REsULTs
Fifteen subjects were ε-4 allele positive. Of these, 12 
were heterozygous (APOE-/4 or APOE-2/4) and three 
were homozygous (APOE-4/4) for APOE genotype. 
The mean age, MMSE score, and B-SIT score, and 
percentage attaining different levels of educational 
status, as well as the ratio of men to women in the 
entire group and stratified by ε-4 allele status are 
shown in Table 1.
Three and six subjects had a MMSE and B-SIT 
score, respectively, outside the normal range. 
There was no significant difference (P=0.266) in 
the frequency of abnormal MMSE scores between 
ε-4 allele positive and ε-4 allele negative subjects. 
Similarly, when educational status and age were 
accounted for, there was still no significant (P=0.199) 
association between abnormal MMSE scores and 
ε-4 allele status. Only one out of the twenty-three 
ε-4 allele negative subjects had B-SIT scores outside 
the normal range, while five out of the fifteen ε-4 
allele positive subjects had B-SIT scores outside the 
normal range; the difference in this frequency was 
significant (P=0.025). In addition, when age was 
accounted for, the significant (P=0.022) association 
between abnormal B-SIT scores and ε-4 allele status 
remained.
DIsCUssIOn
While a curative treatment of cognitive impairment 
is currently impossible, current drug therapies, 
if started early enough, may slow down the 
progression of the condition.  Therefore, it is 
important to diagnose early. A widening of the 
approach to the early diagnosis of cognitive 
impairment is desirable.18 The MMSE is a brief and 
widely used method for assessing cognitive mental 
status.6 It assesses orientation, attention, immediate 
and short-term recall, language, and the ability 
to follow simple verbal and written commands. 
Furthermore, it estimates the severity of cognitive 
impairment at a given point in time, follows the 
course of cognitive changes in an individual over 
time, and documents an individual’s response to 
treatment.19 A number of studies have examined 
the association of performance on the MMSE with 
APOE genotype,7,8 possession of an ε-4 allele being an 
independent risk factor for AD 20 as well as possibly 
non-AD dementias.21,22,2,24 In the present study, 
there was no association between MMSE scores 
and presence or absence of an ε-4 allele, even after 
adjustment for possible confounders. While this is 
in agreement with the findings of some studies,8,25,26 
it is in contrast with the findings of other studies 
which have reported low MMSE scores in those 
with the ε-4 allele.7,27,28,29,0 However, the number of 
subjects in the present study who had MMSE scores 
outside the normal range was low (three out of 40) 
and this may have limited our potential for detecting 
a significant difference between APOE genotype 
groups.
Screening for sensorial impairment is a secondary 
objective in the context of neurodegenerative 
diseases. Impaired olfactory detection predicts 
cognitive decline in non-demented older adults10 and 
has been also observed in first-degree relatives of 
patients with AD.11,12 Few studies have examined the 
association of performance in olfactory tests with 
APOE genotype. In the present study, there was a 
significantly higher prevalence of olfactory deficit in 
non-demented Irish subjects who possessed at least 
one ε-4 allele compared to those who lacked the ε-4 
allele. These findings are in agreement with those of 
Murphy14 who reported significant deficits in odour 
identification in persons with the ε-4 allele, but who 
do not show yet evidence of dementia.14 Furthermore, 
Wang et al.1 reported that in patients with mild 
cognitive impairment, those with ε-4 allele detected 
less odours than those without the ε-4 allele. 
The reason for the higher prevalence of olfactory 
deficit in ε-4 allele positive subjects in the present 
study is unclear. It is tempting to suggest that as 
the olfactory system may be the site of the first 
involvement of the AD process,1 and may explain 
why olfactory dysfunction is among the first signs 
of AD,1 the olfactory deficit in ε-4 allele positive 
subjects may have been due to preclinical AD. 
However, this is unlikely to have been the case, since 
the prevalence of AD in a group of individuals aged 
60 to 69 years is 0.% 2 and if possession of an ε-4 
allele increases risk by up to three-fold, prevalence 
would still only be about 1%. Thus, the reason 
why about a third of ε-4 allele positive subjects 
had an olfactory deficit is still unclear. It is worth 
noting that olfactory impairment is not specific 
for AD type dementia,17 and that, as mentioned 
already, APOE genotype is also a risk factor for other 
dementias.21,22,2,24 However, the subjects in the 
present study were non-demented, as defined by the 
MMSE. Interestingly, recent studies in APOE knockout 
mice have provided evidence for a role for APOE in 
the olfactory process, with APOE deficiency leading 
to substantial delay in olfactory nerve repair.4 APOE 
has been shown to be expressed at high levels in 
human and mouse olfactory bulbs, particularly in 
the olfactory nerve layer and around the glomeruli.5 
These findings raise the possibility that APOE 
genotype may influence olfaction independent of AD 
or other dementias.
In conclusion, the findings of the present preliminary 
work suggest that there is a higher prevalence of 
olfactory dysfunction among Irish individuals at 
genetic risk of dementia. Further investigation is 
required to explore the relationships between APOE 
genotype, olfactory as well as cognitive deficits 
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OLFACTORY FUNCTION IN PEOPLE wITH GENETIC RISK OF DEMENTIA
InTRODUCTIOn
Alcohol use disorders and suicidal behaviours are 
among the most prevalent and damaging of all 
psychiatric phenomena. Worldwide, alcohol accounts 
for 1.8 million deaths (.2% of total) and 58. million 
(4% of total) of Disability Adjusted Life Years (DALYs) 
per annum.1 The burden of alcohol related harm is 
not distributed equally, with industrialised countries 
most affected.1,2 For example, lifetime prevalence of 
alcohol use disorders in the United States has been 
estimated as 20.1% for men and 8.2% for women, but 
these prevalence rates are much lower in countries 
where alcohol use is prohibited or restricted, 
such as the Islamic countries of the Middle East.1, 
Alcohol use and related harm is now a major public 
health problem in Ireland, with levels of alcohol 
consumption the second highest in Europe.2 
Pooled international data from the World Health 
Organization show that completed suicide rates 
for males increase from 22 per 100,000 in the 15 to 
24-year-old age group to 50 per 100,000 in the over 
75-year-old age group. The corresponding rates for 
females are 4.9 and 15.8 per 100,000. Parasuicide 
rates are highest in younger age groups, with the 
parasuicide to suicide ratio increasing from 4:1 in 
older people to as high as 200:1 in adolescents.1 
Suicide has been identified as the leading cause 
of death for Irish men age 15 to 4 years, and 
tackling risk factors such as alcohol intake is of vital 
importance.4
There also exists a strong link between alcohol use 
disorders and suicidality, with both chronic alcohol 
abuse/dependence and acute alcohol intake being 
associated with substantially heightened risks of 
suicidal behaviour.5-8 It has been estimated that one 
fifth to one third of the excess mortality associated 
with alcohol dependence is accounted for by suicide 
and that alcohol abuse/dependence may account for 
15-25% of completed suicides. 9,10 
The relative risk of completed suicide in the alcohol 
dependent compared to the general population 
has been estimated as 60-120 and alcohol abuse/
dependence is second only to depression in the list 
of the commonest psychiatric illnesses associated 
with completed suicide, and is sometimes identified 
as the most common psychiatric diagnosis.5,10,11 A 
metaanalysis has demonstrated the lifetime risk of 
suicide among the alcohol dependent to be 7%, with 
corresponding risks of 6% for affective disorders and 
4% for schizophrenia.12 Furthermore, at a population 
level, rising per capita alcohol consumption and 
Recent alcohol intake and suicidality — 
a neuropsychological perspective
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Background  Alcohol use disorders and suicidal behaviours are among the most prevalent 
and damaging of all psychiatric phenomena in Ireland and worldwide. Furthermore, 
alcohol use both chronic and acute has long been identified as a potent risk factor 
for suicidal behaviour. 
Aims In this paper, the authors review the observational and experimental evidence for 
the acute neuropsychological effects of alcohol intake on suicidal ideation and 
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Search terms employed included ‘alcohol’, ‘suicide’, ‘binge’ and ‘acute alcohol 
intake’.
Results  Cognitive mechanisms implicated include alcohol-induced deficits in attention-
allocation, prospective cognition, autobiographical memory and disinhibition. 
Emotional mechanisms include alcohol-induced dysphoria, depression and 
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Conclusions  This paper serves to highlight the importance of identifying and tackling 
acute alcohol intake and binge drinking as a risk factor for suicidal behaviour.
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higher levels of binge drinking have been seen to 
occur in conjunction with rising rates of completed 
suicides in some countries, such as Ireland, and the 
major anti-alcohol campaign in the former USSR 
in 1985 led to significant reductions in alcohol 
consumption and suicide rates.2,1
While these statistics strongly suggest an association 
between chronic alcohol abuse/dependence and 
suicide, they are based mainly on the results of 
epidemiological and case-control studies and 
provide little information on potential mechanisms 
explaining the interplay between them. In addition, 
relatively little research has focused on the acute 
effects of alcohol intake on suicidal ideation and 
behaviour, in both the alcohol dependent and non-
alcohol dependent.
In this paper, we aim to review the most recent 
literature in the area, focusing primarily on the 
acute neuropsychological effects of alcohol intake 
on suicidal ideation and behaviour. Other factors in 
the relationship between acute alcohol intake and 
suicidality, such as the effects of gender, genetic 
factors and neurochemical and neuroanatomical 
perspectives are also important, but are beyond the 
scope of this paper. The adverse neuropsychological 
effects of recent alcohol intake described in this 
paper are likely to be potentiated considerably 
by psychiatric disorders such as depression and 
attention deficit hyperactivity disorder, organic brain 
disease such as vascular cognitive impairment and 
intellectual disability.14,15,16
Recent alcohol intake and suicidal behaviour-
observational data
High blood alcohol concentrations (BACs) have been 
demonstrated in 46-77% of suicide attempters  and 
-59% of suicide completers.17-24 A more recent review 
found that 10-69% of completed suicides and 10-7% 
of suicide attempters tested positive for alcohol use.25 
In a study of emergency room attenders, higher 
BACs were found among patients attending for 
assessment of suicidality than among those 
attending for other reasons, indicating a possible 
dose-response relationship between alcohol 
and suicidality.7 A recent case-control study 
demonstrated recent drinking (within six hours) to 
be strongly associated with intentional injury (odds 
ratio of 10), and a stronger predictor of intentional 
injury than alcohol dependence.26 Similar findings 
were reported by the Houston case control study, 
with odds ratios of a near lethal suicide attempt 
ranging from 2.4 for alcoholism to 7 for drinking 
within three hours of the attempt.27
Furthermore, alcohol intake in suicidal individuals 
has been associated with use of more lethal suicide 
means and recent alcohol intake has been associated 
with heightened suicide risk in the alcohol 
dependent. 5, 6, 20, 22 Therefore, these findings imply a 
strong relationship between acute alcohol intake 
and suicidality. But what are the neuropsychological 
mechanisms by which this acute effect is mediated?
Cognitive and Emotional Mechanisms
A number of cognitive and emotional processes are 
potentially involved in mediating the effects of acute 
alcohol intake on suicidal ideation and behaviour. 
These different mechanisms may have an additive or 
overlapping effect.
It has been proposed that some individuals consume 
alcohol in an attempt to turn suicidal ideation into 
action.20 This behaviour may be influenced by the 
individual’s own perception of how alcohol will 
affect their mental state (‘alcohol expectancies’). The 
individual may believe that alcohol will give them 
the motivation to attempt suicide or to make that 
attempt painless.28 ‘Alcohol expectancies’ may also 
differ between males and females. Furthermore, if 
an individual drinks alcohol to relieve an unpleasant 
mental state but does not derive any benefit from 
drinking, they may then be propelled into suicidal 
ideation or behaviour.28
Alcohol intoxication can lead to deficits in attention-
allocation, whereby the intoxicated individual is less 
aware of internal and external cues and less able 
to make sense of them, thus leading to a state of 
cognitive constriction. This leads to difficulties in 
problem-solving, with a restricted range of options 
available to the intoxicated individual, a state 
that has also been termed ‘alcohol myopia’. When 
combined with other factors that may accompany 
intoxication, such as a dysphoric mood state and 
disinhibition, the individual may be more likely to 
see death and suicide as a potential solution to a 
problem and act on suicidal ideation, particularly 
if they have had suicidal ideas prior to becoming 
intoxicated.29
‘Alcohol myopia’ can also lead to disinhibition, due 
to deficits in the ability to assess the advantages 
and disadvantages of a particular course of action 
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or behaviour and impairing the individual’s ability 
to identify effective coping strategies. These deficits 
can then lead to an increased likelihood of acting out 
behaviours that would normally have a high degree 
of inhibition conflict, such as self-harm and suicide 
attempts.29
Closely related to cognitive constriction and ‘alcohol 
myopia’ is prospective cognition. Suicide attempters 
have been demonstrated to be less fluent in coming 
up with positive events that might happen in the 
future, and it is possible that, in view of alcohol-
specific effects leading to frontal lobe dysfunction, 
that intoxicated individuals may have similar 
deficits.0 
Finally, deficits in autobiographical memory 
have been proposed to explain trait-dependent 
deficiencies in problem-solving skills.0 In acute 
alcohol intake in some individuals, the combination 
of a dysphoric mood state and constricted cognition 
may possibly lead to the selective recall of unhappy 
autobiographical memories, thus perpetuating a 
dysphoric mood state and increasing the risk of 
suicidal ideation and behaviour. 
The ascending limb of the BAC curve is associated 
with mild euphoria, disinhibition, aggression and 
increased psychomotor activity. While of no clinical 
relevance in normal individuals, this change in 
emotion in the suicidal individual may lead to a 
transient increase in the risk of suicidal ideation and 
behaviour. The descending limb of the BAC curve, 
however, with its associated dysphoria, depression 
and aggression is more likely to lend a malignant 
colour to the cognitive changes described before and 
increase the risk of suicidality.28
In relation to aggression, individuals who are angered 
and not given the opportunity to retaliate may turn 
to alcohol use.1 Furthermore, intoxicated individuals 
may also be more likely to behave aggressively, due to 
a combination of emotional changes and the effects 
of disinhibition alluded to in the previous section.2
COnCLUsIOns
A large amount of observational data exist that 
suggest a strong link between recent alcohol 
intake and suicidality. Mechanisms by which this 
effect is mediated are undoubtedly numerous 
and complex and are not confined solely to the 
neuropsychological perspective described in this 
paper. A discussion of the effects of psychiatric 
disorders such as depression, organic disorders such 
as vascular cognitive impairment and developmental 
disorders associated with low intelligence and life-
long cognitive problems was outside the scope of 
this review. However, the experimental evidence 
supporting this neuropsychological perspective is 
compelling and serves as a potent reminder of the 
dangers of alcohol intoxication and binge drinking in 
relation to suicidal ideation and behaviour. Further 
research on this neuropsychological perspective is 
needed to describe in more detail the cognitive and 
emotional mechanisms involved, and the role of 
other factors such as gender and personality type.
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InTRODUCTIOn
‘Brain death’ describes the irreversible loss of 
brainstem function in a patient receiving artificial 
organ support that delays the onset of cardiac arrest 
and somatic death.1 It is an irremediable event which 
heralds the permanent loss of consciousness. Brain 
death is ultimately followed by circulatory arrest, and 
is internationally recognised as being equivalent to 
somatic death.2 It is generally considered unethical 
and futile to continue to support vital organ function 
once a diagnosis of brain death has been made. A 
potential exception is maternal brain death, where 
a live foetus is present. The mother and foetus are 
two distinct organisms, and the death of the mother 
mandates consideration of the appropriateness of 
continuing maternal somatic support in order to 
prolong gestation to attain foetal viability. Two recent 
cases have been reported in this country in recent 
years,4-6 highlighting the need to carefully consider 
the issues raised by these complex and tragic 
situations.
BRAIn DEATH VERsUs sOMATIC DEATH
The irreversible cessation of brainstem function 
implies death of the brain as a whole.1,7-10 This 
concept is used to determine when death has 
occurred in cases in which the provision of ‘life-
support’ obscures the conventional cardiopulmonary 
criteria of death.7-9 This concept is widely accepted in 
the medical field2, and is legally recognised in most 
countries, including Ireland. The Memorandum on 
Brain Death reinforces this diagnosis in Ireland,11 
though ‘death’ as such is not defined in law in 
this country.12,1 This concept provides the basis for 
cadaveric organ donation. However, there remain 
significant differences worldwide in the diagnostic 
criteria used for determination of brain death.2 Some 
debate does exist in the medical literature regarding 
the equivalence of traditional ‘somatic’ and ‘brain’ 
death.14-17 What is not in dispute is that fact that brain 
death is a totally irreversible, irremediable, and final 
event which heralds the permanent loss of arousal 
and consciousness. There is no recorded case of 
recovery following the diagnosis of brain stem death. 
These findings form the basis for the concept of the 
equivalence of somatic and brain death.
Brain death ultimately is followed by somatic death, 
often within days, despite meticulous supportive 
care.18 While there are rare and exceptional case 
reports of survival for longer durations in the 
literature, it is generally considered unethical and 
futile to continue to support vital organ function 
once a diagnosis of brain death has been made. 
However, in the tragic situation of maternal brain 
death, attempts have been made to sustain maternal 
somatic function with the aim of allowing the 
Maternal brain death — an Irish perspective
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Background Brainstem death is a concept used in cases in which life-support equipment 
obscures the conventional cardiopulmonary criteria of death. Brainstem death 
during pregnancy is an occasional and tragic occurrence.
Aims To consider the ethical, legal and medical issues raised by maternal brainstem death.
Methods Medline and Embase search.
Results The death of the mother mandates consideration of whether continuing 
maternal organ supportive measures in an attempt to attain foetal viability is 
appropriate, or whether it constitutes futile care. There is no theoretical limit to the 
duration of time for which maternal somatic function may be sustained. However, 
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foetal outcome.
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pregnancy to continue until the foetus has attained 
viability. It is not generally considered to be maternal 
life support per se in that maternal brain death, and 
therefore legal death, has occurred.
MATERnAL BRAIn DEATH AnD LIMITs Of 
fOETAL VIABILITy
The key determinant of success of attempts to 
sustain maternal somatic function is the duration 
of time required for the foetus to attain viability. 
However, there are insufficient data regarding the 
effects of maternal brain death on the limits of foetal 
viability. It does seem likely that the physiologic 
alterations and therapeutic interventions necessary 
to sustain maternal somatic function (e.g. the effects 
of vasopressor therapy on utero-placental blood 
flow) would impact adversely on the onset of 
foetal maturity. 
Despite these reservations, it is useful to consider the 
data on premature delivery in the general population 
as a reference point in determining the limits of 
foetal viability in the setting of maternal brain death. 
A foetus born before 24 weeks has little prospect of 
surviving.19 At 24 weeks, a foetus has approximately 
a 20 – 0% likelihood of survival with a 40% chance 
of suffering from severe handicap if born alive.19 At 
28 weeks, there is an approximately 80% chance 
of survival and a 10% risk of severe handicap. A 
gestational age of 2 weeks has generally been 
considered the earliest time at which delivery can be 
made with the best chance of survival and the least 
chance of handicap. At that stage there would be a 
98% chance of survival with a less than 2% risk 
of handicap.19
LIKELIHOOD Of sUCCEssfUL MATERnAL 
sOMATIC sUPPORT
The determination of the likelihood of successfully 
maintaining maternal somatic function for the 
duration necessary to achieve a good foetal outcome 
is of central importance. The rarity of prolonged 
maintenance of somatic function following brain 
death is clear from earlier studies reporting the 
ventilation of patients post brain stem death until 
cardiac arrest supervened. In their series of 1200 
brain dead patients, Jennett and Hessett were 
unable to find a single case of somatic survival 
beyond 14 days.20 Hung and Chen, in a prospective 
study of 7 patients that met the clinical criteria 
for brainstem death, found that 97% developed 
cardiac asystole within seven days despite continued 
full cardiorespiratory support.21 In an older study, 
Jorgensen reported that of 6 patients diagnosed 
as brain dead, 100% developed asystole within nine 
days.22 Median time to cardiac arrest following 
brain death was .5 – 4.5 days in a UK study.2 More 
recently, Shewmon, in his meta-analysis of somatic 
survival following brain death, did report multiple 
cases of prolonged maintenance of somatic function 
following brain death, but acknowledged that was 
very much the exception.24
The longest duration for which successful support of 
maternal organ function following maternal brain 
death has been achieved to date is 107 days.25 The 
woman involved was a 0-year-old who suffered a 
massive brain injury at 15 weeks gestation. She was 
declared brain dead 10 days later, i.e. at 16.5 weeks. 
Vital organ support was provided for 15 weeks and 
two days (i.e. 107 days), and a live infant was delivered 
at approximately 2 weeks gestation. Maternal 
somatic function remained relatively stable up until 
organ support was discontinued following delivery 
of the infant. This raises the potential that support 
of maternal function could have been prolonged for 
longer in this case, had it been necessary. 
In summary, it is possible, at least in theory, to 
sustain maternal somatic function for extended 
periods of time. However, the duration of successful 
maternal somatic support has not been extended 
in fifteen years, despite dramatic advances in organ 
support therapies in the interim. Of importance, the 
successful delivery of a live foetus has never been 
reported where pregnancies were less than 16 weeks 
gestational age at the time of maternal brain death. 
ETHICAL IssUEs
Maternal brain death raises difficult ethical issues. 
While it is clear that the nearer the pregnancy is to 
term, the more likely that there can be a successful 
delivery by caesarean section, the outer limits of 
successfully maintaining a body on life support in 
the absence of brain stem function are unclear. In 
addition, there is no proven management strategy 
to maintain maternal somatic function; therefore 
this can be considered to constitute experimental 
therapy. The question arises as to whether 
attempting to sustain maternal somatic function 
for a prolonged duration following brain death is an 
ethical option. It seems that it can only be considered 
ethical if there is some – albeit poorly quantified 
– hope of success. An alternative viewpoint is that 
this constitutes medical experimentation with little 
or no hope of success. Other issues which require 
r FarraGher et al
detailed consideration with respect to the mother 
include the woman’s right to autonomy, the need 
to respect a body following brain death and the 
woman’s right to die with dignity. Balanced against 
these considerations regarding the mother are the 
ethical issues which centre on the foetus. A key issue 
is an examination of whose interest takes primacy, 
i.e. the interests of the foetus or those of the mother. 
Finnerty et al have raised three possible approaches 
to these ethical issues.26 The first approach is to 
view the subject as a terminally ill, autonomous 
patient; in this case, maternal wishes as expressed 
previously will prevail. With this approach, it is 
particularly important to determine the existence 
of any previously expressed maternal opinions (e.g. 
advanced directive, living wills, discussion with 
family). The second approach is to view the subject 
as a ‘cadaveric incubator’ with no autonomous 
rights; in this case the rights of the foetus prevail. The 
third approach is to view the patient as a voluntary 
organ donor if the patient had previously expressed 
positive views regarding organ donation; in this case 
it could be viewed that she is willing to act as an 
incubator for the benefit of the foetus.26 
The interests and concerns of other family 
members, particularly the next-of-kin, also deserve 
consideration. Further issues may arise where 
there is uncertainty as to the identity of the next 
of kin, such as where the maternal next-of-kin is 
not the foetal next-of-kin. The immediate family 
must be centrally involved in decision-making, be 
offered counselling and made aware of their right to 
independent legal and medical advice. 
LEgAL IssUEs In THE IRIsH COnTExT
The legal rights conferred on the foetus are closely 
linked to the maternal right to therapeutic abortion, 
generally depend on gestational age, and vary across 
Europe. In the Irish Republic, the foetus has been 
accorded a legal right to life, as stated in Article 40.. 
of the Constitution of the Republic of Ireland:
“The State acknowledges the right to life of the 
unborn and with due regard to the equal right 
to life of the mother, guarantees in its laws to 
respect, and as far as practicable by its laws, to 
defend and vindicate that right.”
Article 40.. asserts the right to life of the unborn, 
and treats the foetus as a person having the same 
right to life as any other human being, and it makes 
no attempt to suggest that that right is limited or 
qualified by the stage of foetal development. Mills 
argues that the State, in its application of this Article, 
considers life to begin at implantation.27 Article 
40.., in referring to the ‘equal right to life of the 
mother’, necessarily implies that no interest of the 
mother, or of anyone else, short of a right to life, can 
overbear the right to life of the unborn. Given that 
the mother is legally dead, then in the strict legal 
sense, her right to life is no longer of relevance. 
Sheikh and Cusack, in considering the medicolegal 
implications of this legal protection of the foetus, 
contend that there is an obligation to maintain a 
foetus to a viable gestational age.5 It seems likely 
that a court would consider that if it can be said that 
there is exists a realistic prospect of delivery of a live 
baby, then no-one (whether the Health Authorities, 
the Hospital, a family member or the putative father) 
would be justified in removing life support when 
that would inevitably result in ending the life of 
the foetus.  However, Sheikh and Cusack raise the 
possibility that, if maternal organ support were 
continued, and resulted in the birth of a seriously 
injured child, then that child could then institute 
legal proceedings for negligence.5
In contrast, if the available medical evidence 
suggested that is no realistic prospect of delivery of 
a live baby, then maternal somatic support would 
be considered futile, and would not be permitted.5 
This position is supported by the advice of the then 
Attorney General in the case of a maternal brain 
death at 14 weeks gestation in this country.5,6 He 
stated that withdrawal of ventilation, nutrition and 
fluids would not require legal sanction given that 
the likelihood of successful foetal outcome was 
considered to be remote.5,6 Therefore, even though 
the foetus has considerable legal rights in this 
country, there appears to be no legal imperative to 
continue maternal somatic support where there 
is little likelihood of a successful foetal outcome. 
However, this remains controversial, and has not 
been subjected to legal challenge. 
Finally, the lack of a defined maximum period for 
sustaining maternal somatic function, coupled with 
the protection afforded to the foetus, raises the 
potential for the need to exclude pregnancy, even 
in its earliest stages, in all brain dead females of 
childbearing age prior to terminating somatic support.
MATERNAL BRAIN DEATH — AN IRISH PERSPECTIVE
60 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4
O
R
IG
IN
A
L 
PA
P
E
R
R
EV
IE
w
O
R
IG
IN
A
L 
PA
P
E
R
IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4  61
LI
TE
R
A
RY
 &
 H
IS
TO
R
IC
A
L
R
EV
IE
w
MEDICAL InTERVEnTIOns REqUIRED TO 
sUsTAIn MATERnAL sOMATIC fUnCTIOn
As already stated, there is no medical therapy or 
management strategy which prolongs maternal 
somatic function for prolonged durations of time 
following brain death. The intensive care physician 
is faced with extrapolating from the experience 
of sustaining organ function following brain 
death to allow for organ donation, and consulting 
case reports,25,26,28 and reviews29 in the literature. 
A relatively predictable picture involving loss 
of cardiovascular stability, complete pituitary 
failure, sepsis and bradyarrythmias resulting in 
eventual cardiac arrest emerges.,25,26,28 Support of 
multiple organ systems, including the respiratory, 
cardiovascular and endocrine systems are near 
universal requirements. Nutritional support should 
be instituted early, preferably by the enteral route. 
Specific invasive procedures may be necessary, 
including placement of a tracheostomy to facilitate 
long-term mechanical ventilation, and placement 
of invasive lines including a central venous pressure 
line and an arterial line to facilitate management 
of cardiovascular instability. Pituitary failure is 
likely, mandating hormonal replacement with 
thyroid hormone, corticosteroids and vasopressin 
and management of diabetes insipidus. Insulin 
therapy may be required to manage glucose 
intolerance. Thermovariablity may be particularly 
difficult to manage, and may require heating 
and cooling blankets and repeated septic 
screens. Blood transfusion may be required for 
management of persistent anaemia. The efficacy 
of erythropoietin in this context is not known. 
Maternal thromboembolism must be considered a 
high risk, mandating prophylaxis with fractionated or 
unfractionated heparins. 
Sepsis, in the absence of haemodynamic collapse, 
constitutes the greatest risk to maternal somatic 
function. Repeated episodes of sepsis, including 
recurring [ventilator associated] pneumonias, 
and [urinary catheter associated] bladder and 
kidney infections are likely. Blood stream infections 
are particularly likely, due to the presence of 
intravascular catheters. These infections are likely 
become increasingly resistant to antibiotic therapy 
over a time period of several months in the ICU. Strict 
asepsis, if possible involving isolation of the maternal 
body, within the ICU, is necessary to reduce the 
likelihood of developing sepsis. Consideration should 
be given to strategies to reduce the incidence of 
catheter-associated sepsis, although unproven in this 
context, including the use of antibiotic or bactericide 
coated catheters and/or using tunnelled central 
venous lines. 
COnCLUsIOns
Maternal brain death raises difficult ethical and legal 
issues. A consensus building approach that involves 
broad based consultation including the immediate 
family, appropriate legal advice and external medical 
experts is central to resolving these issues. It is clear 
that there is no theoretical limit to the duration 
of time for which maternal somatic function 
may be sustained. However, successful prolonged 
maintenance of maternal somatic function is rare. 
The right to life conferred on the foetus from the 
earliest stages of gestation in this State may only be 
usefully exercised if there exists some expectation 
of successful delivery of a live baby. If no realistic 
prospect of success exists, then maternal somatic 
support would be considered futile, and should 
not be permitted. It seems reasonable to consider 
prolongation of maternal somatic function to be futile 
if the pregnancy is of less than 16 weeks gestation at 
the time of maternal brain death, given the absence 
of reports of successful delivery of a live foetus in 
these pregnancies. This might be an appropriate cut-
off point in this context. However, the fact that this is 
an arbitrary cut-off point must be emphasised.
Despite these difficulties, there remains an imperative 
to develop guidelines for healthcare providers in 
Ireland regarding how to resolve the issues raised by 
maternal brain death. It is likely that further similar 
cases will arise in this country in the future.
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InTRODUCTIOn
Resistance to Thyroid Hormone (RTH) is a disorder 
of tissue hyposensitivity to the actions of thyroid 
hormone, and in many cases is initially misdiagnosed 
as hyperthyroidism. RTH is characterised by elevated 
thyroid hormone levels and unsuppressed thyroid 
stimulating hormone (TSH) levels, and a varying 
constellation of clinical findings. In the majority of 
cases, RTH is caused by an inherited mutation in 
the thyroid hormone receptor beta. We describe 
an isolated case of RTH without an identifiable 
mutation in the thyroid hormone receptor, the first 
reported such case in an Irish patient, and we review 
the condition with particular reference to non-
thyroid receptor RTH. 
CAsE REPORT
A 21-year-old woman was referred for an 
endocrinology opinion because of abnormal thyroid 
function tests. She had attended her general 
practitioner complaining of fatigue. On questioning, 
she did not complain of symptoms suggestive of 
hyperthyroidism. She was on no medications and 
had no significant past medical history. There was no 
family history of thyroid dysfunction.
Physical examination revealed her pulse to be 80 
beats per minute and regular. She weighed 52.6 
kgs and had a goitre. There were no stigmata of 
hyperthyroidism on physical examination.
Thyroid function tests demonstrated a total 
thyroxine (TT4) of 217 nmol/L (69-141) and a TSH of 
1.01 mU/L (0.4-4.0). Thyroid antimicrosomal and 
antithyroglobulin antibodies were negative.
A diagnosis of antibody-negative Graves’ Disease 
was suspected and the patient was commenced on 
carbimazole 15 mg twice daily.
On review in November 1999, the patient complained 
of increased fatigue. The TT4 was 158 nmol/L but the 
TSH was now elevated at 11.8 mU/L. Two months later, 
following reduction in the dosage of carbimazole, 
the TT4 was 169 nmol/L but the TSH remained 
persistently elevated at 6.9 mU/L. The carbimazole 
was discontinued. Two months following cessation 
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of therapy, the TT4 was 28 nmol/L, TSH 1.47 mU/L 
and total triiodothyronine (TT) and free T4 were 
also elevated at .7 nmol/L (0.8-2.5) and  pmol/L 
(10.-24.5) respectively. Levels of Sex-Hormone 
Binding Globulin, CPK, Serum Ferritin, and Alkaline 
Phosphatase were tested and were normal, apart 
from mildly elevated SHBG of 129 nmol/L (normal 
range 18.6-117).
Based on the pattern of thyroid function testing, 
the diagnoses of RTH or TSH-producing pituitary 
adenoma were considered. The family of the index 
case volunteered to have thyroid function testing 
performed. Neither parent nor either of the patient’s 
two sisters demonstrated a similar abnormality in 
their thyroid function tests. Thyroid function tests 
were also measured at the University of Chicago 
(Figure 1). TRH stimulation testing performed in the 
index case demonstrated a normal TSH response 
to the administration of intravenous TRH (Table 1). 
Magnetic Resonance Imaging of the pituitary gland 
was normal (not shown). These results suggested 
that the most likely diagnosis was RTH. To confirm, a 
triiodothyronine (T) suppression test was performed. 
Oral T, at a dose of 50 microgrammes a day for three 
days, followed by 100 microgrammes a day for a 
further three days, was administered to the patient 
and to a control with no history of thyroid disease 
and normal thyroid function tests as baseline. On 
day seven, 200 microgrammes of TRH was given 
intravenously, and samples taken for measurement 
of FT4, TSH and prolactin at 0, 15, 0, 45, 60, 90 and 
120 minutes. Results for the patient and the control 
are shown in Table 2 and Figure 2, and demonstrate, 
in contrast to the control in whom the TSH was fully 
suppressed, failure of complete suppression of TSH in 
the patient, and preservation of the response to TRH, 
despite the high doses of exogenous T.
These results are consistent with a diagnosis of 
RTH. DNA was isolated from peripheral blood and 
sent, together with a skin biopsy, to the University 
of Chicago for genetic analysis. The entire thyroid 
hormone receptor beta gene (both beta 1 and beta 
2) was sequenced from genomic DNA and from 
cDNA reverse transcribed from fibroblast beta 1 
mRNA. No mutations were found. A diagnosis of 
RTH without mutation in the thyroid hormone 
receptor beta was made.
DIsCUssIOn
Resistance to thyroid hormone, an uncommon 
condition thought to occur in 1 in 50,000 births,1 
results from a defect in the normal signalling 
pathways that mediate the intracellular effects of 
thyroid hormone.2,  Four isoforms of the thyroid 
hormone receptor (TR) exist: TRα-1 and TRα-2, 
transcribed from a gene on chromosome 17, and 
TRβ-1 and TRβ-2, transcribed from chromosome . 
Of these only three function as receptors proper 
since TRα-2 does not bind thyroid hormone. TRs act 
as hormone-dependent transcription factors which 
bind to nuclear DNA at specific sites named thyroid 
response elements (TREs), located in the promoter 
regions of target genes, and thus positively or 
negatively regulate gene transcription. Binding of TRs 
to TREs occurs in the context of dimerization with 
a number of other members of the steroid thyroid 
hormone receptor superfamily such as the Retinoid X 
Receptors (RXRs). In the absence of thyroid hormone, 
unliganded TRs bind to TREs and down-regulate the 
expression of the target genes by associating with 
various proteins known as co-repressors (e.g. nuclear 
receptor corepressor (NCoR) and silencing mediator 
for retinoid and thyroid hormone receptors (SMRT)). 
When circulating TH binds to the thyroid hormone 
receptor, however, the co-repressors are replaced by 
various co-activator proteins (e.g. the steroid receptor 
coactivator (SRC) complex). These coactivators 
interact with the TR-TH complex to up-regulate gene 
expression to levels well above the baseline level in 
the absence of TRs. 
Most cases of RTH result in a receptor with decreased 
affinity for circulating thyroid hormone, or impaired 
interaction with the aforementioned co-activators, 
so that higher levels of circulating thyroid hormone 
are required to mediate the desired intracellular 
effects. This results in the characteristic pattern of 
abnormal TFTs, where a higher than normal level of 
thyroid hormone is needed to suppress pituitary TSH 
release into the normal range. Most cases of RTH are 
inherited in an autosomal dominant manner and 
result from mutations in the TRα gene, resulting in 
single amino acid substitutions in the ligand-binding 
domain. A rare autosomal recessive form of RTH, 
caused by a deletion in the TRα gene, also exists and is 
characterised by deaf-mutism in association with the 
abnormal thyroid function tests.4
 
The clinical manifestations of RTH are quite variable.5,6 
Most patients are eumetabolic, with a normal 
basal metabolic rate and normal serum markers of 
metabolism, such as creatine kinase, sex-hormone 
binding globulin, ferritin or cholesterol. Thyroid 
enlargement is the most common physical finding 
Jh MCDerMott et al
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Table 1
TRH TEST
TIME POST TRH (MINS.) TSH LEVEL (MU/L)
0 1.5
15 12.0
0 16.6
45 1.0
60 9.77
90 6.1
120 4.11
180 2.8
Table 2
T3 SUPPRESSION TEST
DAY DOSE LT3 TSH PATIENT 
(mU/L,NORMAL 0.4-4)
TSH CONTROL 
(mU/L, NORMAL 0.4-4)
1 50 μg
2 50 μg
3 50 μg
4 100 μg
5 100 μg
6 100 μg 0.12 0.0
Figure 1 —
THYROID FUNCTION 
TESTING IN PATIENT 
(R2203, HALF SHADED) 
AND FAMILY. DATES 
OF BIRTH ARE BELOw 
THE SUBJECTS’ 
SYMBOLS. ABNORMAL 
RESULTS ARE SHOwN 
IN RED. TRT3, TOTAL 
REVERSE T3; FT4I, 
FREE T4 INDEX; TG, 
THYROGLOBULIN; TPO, 
THYROPEROXIDASE; 
AB, ANTIBODY
Figure 2 —
TRH TEST POST T3 
SUPPRESSION (DAY 7)
TRH STIMULATION FOLLOWING T3 SUPPRESSION
TIME (MINS)
TS
H
 (m
U
/L
)
0
0.5
1
1.5
2
2.5
3
3.5
1 2 3 4 5 6 7
Control
Patient
Family Mby (Nov 2000)
I
II
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and up to 80% of patients have a sinus tachycardia. 
Other findings, such as hyperactivity, learning 
disability, short stature, and delayed bone age, occur 
less frequently. Considerable variation in phenotypic 
features is seen not only between families with 
different TRα mutations but also between members of 
same family, who harbour the same mutation.7 This 
within family variability may be explained by variable 
degrees of expression of the wild-type TR, differences 
in distribution of the various TR isoforms between 
different tissues or genetic variability in coactivators, 
corepressors, or dimerization molecules involved in 
thyroid hormone action.
 
The presentation of our patient was fairly typical 
of the condition. The non-specific complaint of 
fatigue was attributed to her abnormal thyroid 
function tests (despite her clinically euthyroid state 
and her normal TSH), and she was commenced on 
carbimazole. Unfortunately, many patients with RTH 
are mistakenly diagnosed with hyperthyroidism at 
initial presentation and are treated with anti-thyroid 
medications or subjected to thyroid surgery.6, 8
The majority of patients with RTH have a first-
degree relative with the condition.2 When RTH is 
suspected, therefore, a sensible first step in the 
diagnostic evaluation is to test the first-degree 
relatives of the suspected case. A similar abnormality 
in thyroid function tests in a parent or sibling 
immediately makes RTH the likely diagnosis, 
and further investigations to exclude the main 
differential diagnosis, a TSH-secreting adenoma, 
assume less importance. In this respect, our patient 
was somewhat atypical, as her family members had 
normal thyroid function tests and, therefore, further 
testing was required to confirm the diagnosis of 
RTH. Such sporadic cases of RTH, likely due to de novo 
mutations, have been reported in 18% of families 
with the condition.2 
The T suppression test 2 is a useful aid in the 
diagnosis of RTH, and also gives an insight into the 
underlying pathophysiological processes of the 
disease. Because of resistance to the action of T at 
the pituitary thyrotroph level, the normal feedback 
inhibitory effect of T on pituitary TSH release is 
diminished. Despite the high doses of exogenous 
T given to our patient, TSH was not suppressed to 
undetectable levels and retained responsiveness to 
TRH. The contrast with the control subject is obvious, 
and the failure of TSH suppression under these 
experimental conditions makes it easy to appreciate 
why TSH levels remain normal in the face of the often 
comparably minor elevations of T and T4 in RTH. 
The T-suppression test is not necessary if one can 
demonstrate a mutation in the thyroid hormone 
receptor. The patient reported here, however, had no 
mutation on genetic testing. Cases of RTH without a 
TRβ mutation (non-TR RTH) have been described in the 
past, but, to our knowledge, this is the first reported 
case of non-TR RTH in an Irish patient. In 1996, Weiss 
and colleagues9 reported the first such case of non-
TR RTH, in a female patient with the classical RTH 
phenotype who had no detectable mutation of the 
TRβ gene and also no linkage with the TRα gene. 
Subsequently, Pohlenz and colleagues,8 from the 
same laboratory, described five further families with 
RTH and no detectable TRα mutation, and concluded 
that non-TR RTH is present in approximately 10% of 
families with the RTH phenotype. Interestingly, four of 
the six families described appeared to have developed 
new mutations causing RTH (as in these families 
both parents of the index case had normal thyroid 
function), and a de novo mutation must also be 
present in the case we describe. Of note, in addition to 
sequencing of the TRβα gene, four of the six families in 
this series had sequencing of the TRα gene performed, 
and no mutation was detected. A TRα mutation is 
now considered to be a very unlikely cause of RTH, as 
no such mutation has ever been discovered in RTH 
patients, and mice deficient in TRα-10 or with point 
mutations in the TRα- gene11,12 do not exhibit the RTH 
phenotype. Our patient, therefore, was not tested for a 
TRα mutation. 
So what is the cause of RTH in patients with no 
mutation in the thyroid hormone receptor? A defect 
in any of the steps involved in the signalling pathway 
described above could, conceivably, result in RTH, and 
a defect in one or more of the cofactors involved in 
thyroid receptor function is believed to be the most 
likely explanation. The discovery that mice with 
a deletion in the SRC-1 cofactor manifest the RTH 
phenotype gives credence to this belief, 1 and RXR-
g-deficient mice have also been found to have a mild 
form of RTH.14 As yet, however, no specific cofactor 
dysfunction resulting in non-TR RTH has been 
described in humans, and linkage analysis performed 
in four of six families with the condition failed to 
demonstrate involvement of the SRC-1 cofactor, or 
the RXR coregulator, 15 in human disease. The search 
for the specific cause of non-TR RTH continues.
DOB 9.24.4 4.1.71 11.19.77 2.12.78 12.16.46
Normal Range
Sample # R205 R2060 R2206 R220 R2204
TT4 (μg/dl) 9.0 121 10.1 18.5 8.4 5.0-11.8
TT (ng/ml) 124 162 1 213 112 90-185 in children 100-205
TrT (ng/ml) 19.9 24.4 22.2 71.6 17.6 14.5-0.0
FT41 9.1 9. 10.5 20.0 8.2 6.0-10.5
TSH (mU/L) 0.8 2.4 1.0 1.8 2.0 0.4-.6
TG (μg/L) 5 27 8  4 1-25 in children up to 40
TPO/TG ab 20/40 80/- -/- -/- -/- Neg
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In summary, we report a case of RTH where an 
initially typical presentation led to the eventual 
diagnosis of RTH, after a period of treatment with 
anti-thyroid medications. Subsequent investigations 
confirmed the rare diagnosis of RTH without an 
identifiable mutation in the thyroid hormone 
receptor gene, the first reported case of its kind in an 
Irish patient. The normal thyroid function tests in the 
first-degree relatives of the patient suggest recessive 
inheritance or a de novo mutation. This case 
illustrates the point that a high index of suspicion 
for RTH in patients presenting with the characteristic 
pattern of abnormal thyroid function tests, could 
help avoid unnecessary and potentially harmful 
treatment for hyperthyroidism. 
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Irish Neonatal Mortality Statistics 2002
Dear Editor
The Neonatal Mortality Survey, conducted through 
the auspices of the Faculty of Paediatrics of Ireland, 
provides important data on the trends in deaths of 
all live born Irish (Republic of Ireland) infants who are 
greater than 500g birth weight and who die in the 
first 28 days of life.1,2, The term Neonatal Mortality 
Rate (NMR) refers to the number of deaths expressed 
per 1,000 live births. Early Neonatal Mortality Rate 
(ENMR) specifically examines those deaths occurring 
within the first seven days of life. Corrected Neonatal 
Mortality Rate (CNMR) refers to those deaths 
that occur as a result of causes other than lethal 
congenital malformations.
Twenty five of the 26 Irish Neonatal/Paediatric 
centres, including all three Dublin maternity 
hospitals, responded to the 2002 Neonatal Mortality 
Questionnaire, giving a response rate of 96%. There 
were 60,521 live births in Ireland in 2002. One 
hundred and eighty seven neonatal deaths occurred 
during this period. The Neonatal Mortality Rate 
was .1/1000 live births with a Corrected Neonatal 
Mortality rate of 1.8/1000 live births. Early neonatal 
deaths accounted for 81% of the total neonatal 
mortality.
Post mortems were performed in 6 (4%) infants 
(Figure 1). Deaths were classified into (1) Congenital 
malformations, (2) Prematurity, () Asphyxia and 
(4)‘other causes’. 
Congenital Malformations represented the greatest 
proportion of deaths (44.5%; n=8) followed by 
prematurity (6%; n=67). Fourteen deaths occurred 
as a result of asphyxia (7.5%), twelve occurring 
in term infants. Of the deaths due to Congenital 
Malformations, chromosomal abnormalities (n=16) 
and cardiac malformations (n=15) accounted for 
the greatest proportion. Ten deaths occurred as a 
result of renal anomalies with seven neonatal deaths 
secondary to a congenital diaphragmatic hernia. 
Neural tube defects and other central nervous 
system abnormalities accounted for 11 deaths 
during this period. Other congenital malformations 
included non-chromosomal syndromes (n=), 
skeletal dysplasias(n=6) and primary pulmonary 
hypoplasias(n=4). Sixty-seven deaths were 
documented as being primarily due to Prematurity. 
E Finan, 
SM Gormally
Dept. of 
Neonatology, Our 
Lady of Lourdes 
Hospital, Drogheda, 
Co. Louth
CORRESPONDENCE
Figure 1 —
TRENDS IN NEONATAL 
POST MORTEM RATES 
1987 – 2002
Figure 2 —
TRENDS IN IRISH 
NEONATAL AND 
CORRECTED 
NEONATAL 
MORTALITY 
1987 – 2002
Fifty (75%) of these occurred in the Extremely Low 
Birth Weight group. Intraventricular haemorrhage 
was cited as a principal cause of death in 1% of 
preterm deaths.
Causes of death other then the three main 
Wigglesworth categories (n=2) included meningitis 
(n=), sepsis (n=), Sudden Infant Death Syndrome 
(n=), necrotising enterocolitis (n=2) and hydrops 
fetalis (n=).
The annual National Neonatal Mortality Survey 
serves as an important audit of Irish perinatal care. 
The response rate of 96% for 2002 has been the 
highest to date and is indicative of the dedication of 
Irish paediatricians and neonatologists to monitoring 
neonatal outcomes. Irish Neonatal Mortality and 
Corrected Neonatal Mortality Rates have shown a 
steady decline over the past 15 years (Figure 2).1,2 In 
1987, when this data were first examined, NMR and 
CNMR were 5. and ./1000 live births respectively. 
This compares with rates of .1 and 1.8/1000 live 
births in 2002. These figures have reached a plateau 
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since 2000. As with previous years, congenital 
malformations and prematurity account for the 
greatest proportion of neonatal deaths.1,2,4 In 1987, 
asphyxial deaths accounted for 8% of neonatal 
mortality. This figure fell throughout the 1990s with 
the lowest level at 2.1% in 1999. However deaths 
attributable to asphyxia have risen in the past 
three years.4 In 2002, 12 full term asphyxial deaths 
occurred. While this trend is disquieting, it may be 
a reflection of earlier withdrawal of intensive care 
in asphyxiated infants deemed to have a hopeless 
outcome, rather than being a reflection of poorer 
obstetric care. Also the increased asphyxial trend 
has occurred during a period when there has been a 
dramatic increase in the number of asylum seekers 
into Ireland, many of whom have had poor antenatal 
care. Further analysis of this type of trend is limited 
within the confines of the Irish Neonatal Mortality 
Survey in its present format. In an effort to encourage 
a meaningful response rate from Irish paediatricians, 
the amount of information that can be requested 
on the questionnaire is limited. To address this 
shortcoming, argument could be made for future 
development of a confidential, government-funded, 
enquiry into Stillbirths and Neonatal Deaths similar 
to the UK CESDI model.5 Such an auditing system 
would provide a robust framework for the evaluation 
of current obstetric and neonatal practices and 
services in Ireland.  It would also provide a basis on 
which to plan future developments in these areas.
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Using HIPE data as a research and 
planning tool
Dear Editor
An important role for university based researchers 
and peer-reviewed journals is to continually progress 
the research agenda. This has begun by your recent 
publication of our article.1 Notwithstanding the 
detailed defence of the operation of the system in 
your simultaneously published response,2 it is clear 
that the operators of the system agree with at least 
some of our analysis and, as their response indicates, 
they have themselves been considering some of 
the issues we have raised. We reiterate our most 
important conclusions and invite the operators of 
the system to work with us and the wider research 
community in bringing them about. These are:
extend the system to cover private hospitals, adopt 
routine small area and socio-economic coding and 
adopt unique, albeit confidential, personal identifiers.
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A reply to Miriam Wiley’s response to paper ‘Using HIPE data as a research and planning 
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A Malone
Correspondence in response to a book 
review published in Vol 174;2:70
Dear Editor
I am surprised to hear myself being called an 
egocentric in CS Breathnach’s review of my 
biography of Dr Malachy Smyth, ‘A Life in Medicine’ 
in volume 174 of the Irish Journal of Medical Science. 
I would sincerely like to know where he draws that 
conclusion considering I haven’t put any of myself 
into the book.
Could he also tell me where the chronology falls 
down? I would be intrigued to know this as none 
of the dozen or so reviews of the book that have 
appeared so far have noticed any discrepancy.
I think there were about four misprints, which is 
about average. He calls them ‘scarlet’. Could he 
please explain? [Perhaps the book was found in his 
surgery and became inadvertently doused in blood!]
I have no knowledge of CS Breathnach’s expertise 
in anatomy and physiology in UCD but he 
should familiarise himself better with literary 
terminology before he next launches his spleen. 
For his information, a ‘ghosted’ autobiography is a 
contradiction in terms.
Authorial ghosts, by definition, are behind the scenes. 
There are co-written autobiographies, to be sure, but 
this is not one such. It is written in the third person. 
That makes it a biography. Is CS Breathnach familiar 
with what a biography is? It is a life story of one 
person written by another. In this case, a biography 
of Dr Smyth by me. Where do ghosts come in? Where, 
for that matter, does autobiography come in?
This is one of the strangest ‘reviews’ I have ever read.
A misunderstanding: the autobiographer was 
Malachy, not Aubrey the ghost.
The fundamental trouble with A Life in Medicine 
is that Aubrey Malone relayed Malachy Smyth’s 
account without reference to other medical authors, 
a norm in medical biography. The ghost in the 
machine is the uncritical acceptance of Dr Smyth’s 
presentation of his work – undoubtedly valuable – on 
intervertebral discs. W J Mixted and J S Barr’s paper 
in New England Journal of Medicine in 195 (211: 210-
215) is taken as the point of departure on ‘rupture of 
intervertebral disc with involvement of the spinal 
cord’. By 1946 this explanation of sciatica was fully 
endorsed in Watson-Jones’s Fractures and Joint 
Injuries a decade before Malachy’s work in Leeds 
which was published in 1958. Anachronisms and 
misprints were euphemisms for this deeper malaise, 
and it would be futile to take part in a point to point 
refutation in a ‘20 yards hurdle’ (p. 17 of the book), 
one of the strangest athletic contests ever run, even 
in College sports.   Punning may be the lowest form 
of wit, but Hilaire Belloc’s comment and hope that 
‘His sins were scarlet, but his books were read’ did 
not catch the eye in the bloody field.
C S Breathnach
Dept of Human 
Anatomy & 
Physiology, 
University College 
Dublin
Reply to Aubrey Malone
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Gerry’s Real World Guide to 
Pharmacokinetics and Other Things
GM Woerlee
ISBN: 1-90527-16-2
Price: £9.95
M Langdon
College of 
Anaesthetists, Royal 
College of Surgeons 
in Ireland, 
22 Merrion Square 
North, Dublin 2
GM Woerlee introduces his most recent publication, 
Gerry’s Real World Guide to Pharmacokinetics and 
Other Things, as “written for all those wishing to 
learn about basic principles of pharmacokinetics 
as applied to anaesthetic drugs. It is intended as an 
entertaining guide to these things with a maximum 
of practical common sense and a minimum of 
mathematical knowledge”. Dr Woerlee’s credentials 
to guide the reader on this pharmacological tour 
include 2 years teaching and anaesthesia practice in 
Leiden, the Netherlands following specialist training 
in Western Australia and England.
The ‘Other Things’ referred to in the title are 
comprised of humorous, if sometimes clichéd, 
observations of the human condition as it is played 
out in the operating theatre, philosophical musings 
and quotes from erudite sources ranging from the 
Koran to Nietzsche.
This small monograph is targeted toward all levels 
of trainees, consultants and nurses with a common 
interest: Clinical Anaesthesia. It reaches this 
audience through a range of illustrative operating 
room scenarios discussed in a conversational tone. 
Each chapter presents a new patient very much in a 
‘Problem Based Learning’ format. 
As in all simulated clinical scenarios, these story lines 
rely on the reader’s suspension of reality. Throughout 
each clinical case, a senior consultant anaesthetist 
questions a registrar under his mentorship about 
the pharmacology of anaesthetic agents in the 
practical setting. Doctor Gerry is introduced as an 
‘experienced crusty older anaesthetist, intolerant of 
fools and a bit of a pharmacokinetic freak’. The hard 
working but often pharmcokinetically challenged 
registrar, Doctor Bob, approaches his first day ‘with 
some trepidation’. 
While the role-play is occasionally pithy the premise 
of this book works. The reader is drawn along as a 
silent observer of this educational foray. The buzz 
of the operating room accompanies Doctor Gerry’s 
probing questions and comprehensive answers. 
Through practical examples, the reader is gently 
reacquainted with core pharmacokinetic concepts.
The ten chapters offer unambiguous explanations 
of principles such as plasma half-life, drug 
distribution and elimination. Relevant tables are 
included in the text while detailed tables are 
reserved for the appendices. The text could benefit 
from more diagrams (invaluable teaching tools 
in pharmacokinetics) but the author may have 
sacrificed these to preserve the informal style.
GM Woerlee is an anaesthetist’s anaesthetist. I 
strongly suspect that he may share more than some 
character traits with Doctor Gerry though I believe 
GM Woerlee to be more pleasant and less patriarchal. 
He is known for his lecture at the European Sceptics 
Conference and publication ‘Mortal Minds: A 
Biology of the Soul and the Dying Experience’ which 
demystify the physical sensations reported in near 
death experiences. 
Anaesthetists in any clinical practice will find the 
authenticity of this book’s illustrative cases resonant 
which contributes to the realization of its objective - 
to make pharmacology clinically relevant. Its success 
ultimately results from short digestible chapters that 
approach an interactive educational style. This book 
is not a core textbook; a fact that makes it all the 
more enjoyable to read.
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